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Cover figure: Schematic representation of skeletal muscle regeneration 
following a crush injury, showing the potential role of cell expressing Cx39, 
Cx40, Cx43, and Cx45 during satellite cell activation, proliferation, their 
differentiation in myoblasts and fusion to form new myotube. 
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SUMMARY 
 
 
 
The first aim of present work was to perform a comparative spatial and temporal 
analysis of connexin (Cx) Cx37, Cx39, Cx40, Cx43, and Cx45 expression in developing 
skeletal muscle and in the adult regenerating skeletal muscle in response to crush injury. 
Among the Cxs examined, only the Cx39, Cx43 and Cx45 were found expressed during 
embryonic life and progressively reduced during early postnatal life to become dramatically 
expressed at very low levels like Cx43 and Cx45, or to be undetectable like Cx39 in the adult 
muscle. Cx37 and Cx40 were found expressed at low levels and were localized in the 
endothelial cells. In the adult skeletal muscle, various kinds of trauma promote proliferation 
of satellite cells that differentiate into myoblasts forming new myofibers, or to repair the 
damaged one. Within 24h from injury, Cx37 expression was upregulated in the endothelial 
cells of blood vessels, and, 5 days after injury, Cx37-expressing cells were found inside the 
area of lesion and formed clusters generating new blood vessels with endothelial cells 
expressing Cx37. Three days after injury, Cx39 mRNA was selectively expressed in 
myogenin-positive cells, forming rows of closely apposed cell nuclei fusing in myotubes. 
Cx40 mRNA-labeled cells were observed within 24h from injury in the endothelium of blood 
vessels, and, 5 days after lesion, Cx40-labeled cells were found inside the area of lesion-
forming rows of myogenin-positive, closely apposed cells coexpressing Cx39. Within 24h 
from lesion, both Cx43 and Cx45 mRNAs were upregulated in individual cells, and some of 
them were positive for M-cadherin. Three days after injury, a large number of both Cx43 and 
Cx45 mRNA-labeled and myogenin-positive cells were found inside the area of lesion.  
Taken together, these results show that at least four Cxs, out of five expressed in 
regenerating skeletal muscle, can be differentially involved in communication of myogenic 
cells during the process of cell proliferation, aggregation, and fusion to form new myotubes or 
to repair damaged myofibers. 
The second aim of this study was to examine how low-intensity endurance exercise 
affects the regeneration process in dystrophin-deficient skeletal muscle. The lack of 
dystrophin in mdx mice, an animal model for Duchenne muscular dystrophy, leads to cycles 
of muscle degeneration and regeneration processes. Male adult mdx and wild type mice were 
subjected to low-intensity endurance exercise by running on a motorized Rota-Rod for 5 
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days/week, for 4 weeks at progressively increasing loads. Exercised mdx mice showed a trend 
to lower body weight gain and positive effect on the degree of fatigue. Histomorphological 
analysis showed a significant reduction of both muscle necrosis foci and regeneration 
processes in the gastrocnemius and quadriceps muscles of exercised mdx mice. The reduction 
of regeneration process was also evaluated by examining the protein expression of Cx39, as a 
specific gene expressed during regeneration process of  injured muscles. While Cx39 was not 
expressed both in wild type exercised nor in sedentary mice, it was markedly increased in 
sedentary mdx mice, because of active degeneration/regenerating process, and dropped to very 
low levels in exercised mdx mice, suggesting a reduction of muscle regeneration process. 
This study has shown that specific low intensity endurance exercise induces a strong 
beneficial effect on the regeneration of dystrophic muscle and may have therapeutic value at 
least to decrease progression of muscular dystrophy and in less extend for strengthening 
dystrophic muscle. 
 
 
1 
Dott.ssa M. Frinchi 
BACKGROUND 
 
 
 
Skeletal muscle Development  
 
All the skeletal muscle of the body and the limbs derive from paraxial mesoderm 
which segments into somites on either side of the neural tube and notochord. The ventral 
part of the somite, the sclerotome, will contribute the cartilage and bone of the vertebral 
column and ribs, whereas the dorsal part of the somite, the dermomyotome, give rise to the 
overlying derm of the back and to the skeletal muscles. Early myogenesis is governed by a 
complex set of morphological and migratory events which begin with the colonization of the 
medial myotome by cells originating from the dorsomedial lip of the dermomyotome 
(Ordahl and Le Douarin 1992; Denetclaw, Jr. et al. 1997). 
A number of homeobox genes are implicated in the survival, delamination and 
migration of muscle progenitor cells from the hypaxial dermomyotome to sites of muscle 
formation elsewhere in the body and limbs. Lbx1 is one of genes expressed in migrating 
cells and in the hypaxial myotome of somites. In mice lacking  Lbx1 gene, cells fail to 
migrate correctly, as evidenced by accumulation beside the somite at the hindlimb level, 
mislocation of ventral muscle cells to dorsal muscles at the forelimb level, and retarded 
migration/differentiation in the hypoglossal chord. The c-Met receptor tyrosine kinase and 
its ligand hepatocyte growth factor (HGF) are essential for the delamination of cells from 
the dermomyotome at all axial levels and are potentially important also for guiding 
migration. In their absence, infact, migrating muscle progenitors and the muscles form are 
absent (Birchmeier and Brohmann 2000). Pax3, a member of Pax gene family, is an other 
important regulator of myogenesis. Pax3 have a crucial role in the development of the 
hypaxial musculature and the long range migration of muscle precursor (Tremblay et al. 
1998). It also plays a key role in the establishment/survival of cells in the hypaxial 
dermomyotome, and in the delamination of myogenic progenitors (Tajbakhsh and 
Buckingham 2000). Moreover Pax3 is necessary for MyoD activation, a member  of MyoD 
family of helix-loop-helix transcription factors. This family includes four different members: 
MyoD, Myf5, myogenin and the myogenic regulatory factor-4 (MRF4) which are expressed 
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in a hierarchical manner during the myogenesis process. Myf5, like MyoD, is expressed in 
the early stage, and it is implicated in the establishment and maintenance of muscle 
progenitor lineages. Newborn mice mutant for both MyoD and Myf5, infact, lack skeletal 
muscle and are devoid of myoblasts (Rudnicki et al. 1993). Studies on cultured cells and 
mutant mouse embryos have demonstrated that Myf5 and MyoD are involved in determining 
skeletal muscle cell fate with a potential role in remodeling chromatin and regulating the 
crucial balance between cell proliferation and differentiation. For example, it has been 
shown an interaction between MyoD and the histone transacetylases pCAF and CBP/p300 
which function as transcriptional coactivators. Furthermore, acetylation of MyoD by pCAF 
(Sartorelli et al. 1999) or p300 (Polesskaya et al. 2000) is necessary for myogenic 
conversion and increases its affinity for muscle specific promoters, hence promoting 
myogenic differentiation. In contrast, interaction between histone deacetylase HDACI and 
MyoD prevents premature activation of the myogenic programme in dividing myoblasts 
(Mal et al. 2001). 
As well as Pax3, also Wnt family members, that are expressed in the neural tube and 
dorsal ectoderm, synergize with Sonic hedgehog (Shh), produced by the notochord and 
floorplate, and induces somatic expression of MyoD and Myf5 (Munsterberg et al. 1995; 
Munsterberg and Lassar 1995; Stern and Hauschka 1995; Pownall et al. 1996). This suggest 
that initially precursor cells responding to environmental signal will activate, independently, 
one or the other gene and that only in the second time the majority of myogenic cells can 
express either MyoD and Myf5. 
As above mentioned, other two important members of MyoD family are Myogenin and 
MRF4, which are required for normal biochemical and morphological differentiation of 
skeletal muscle, but are not required for commitment of cells to the myogenic lineage (Hasty 
et al. 1993; Nabeshima et al. 1993; Olson et al. 1996). In the late stage of myogenesis, 
infact, proliferating myoblasts withdraw from the cell cycle to become terminally 
differentiated myocytes and express MRF4. Myogenin and MRF4, and subsequently muscle-
specific genes such as myosin heavy chain (MHC) and muscle creatine kinase (MCK). 
Myogenin-deficient embryos die perinatally, due to a deficit in myoblast differentiation as 
evidenced by an almost total absence of myofibers in these mutants (Hasty et al. 1993; 
Nabeshima et al. 1993). Similarly, MRF4-deficient mice display a range of phenotypes 
consistent with a late role for MRF4 in the myogenic pathway (Patapoutian et al. 1995; 
Rawls et al. 1995; Zhang et al. 1995; Yoon et al. 1997). Moreover some data show that 
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Myogenin and MRF4 are differentially expressed in differentiated muscles and regulate 
contractile protein target genes (Charbonnier et al. 2002; Mak et al. 1992; Yutzey et al. 
1990), that include genes involved in fast and slow fiber differentiation and regeneration 
(Hinterberger et al. 1991; Jacobs-El et al. 1995; Nicolas et al. 2000). 
Not only the member of MyoD family are responsible of the skeletal muscle 
development. Infact, the MRFs,  are assisted by the myocyte enhancer factor 2 (Mef2) family 
of transcription factors in order to mediate expression of muscle-specific genes (Black and 
Olson 1998). Mef2 genes are expressed widely during development. Mef2 proteins bind to 
an A/T-rich DNA sequence element (C/TTA(A/T)4TAG/A) which is found in the promoters 
of many muscle-specific genes (Gossett et al. 1989). Mef2 and MyoD interact directly in 
vitro and synergistically activate transfected reporters driven by E boxes and Mef2 binding 
sites (Molkentin et al. 1995). 
Another notable family of transcription factors critical for myogenesis is the Six family 
of homeodomain proteins. There are six members of the Six family in mammals, each 
playing different roles in various developmental contexts (Kawakami et al. 2000). One of 
these members is Six1. Some studies had demonstrate that mice lacking Six1 have impaired 
primary myogenesis and delayed expression of myogenin and MyoD in limb buds, 
indicating a positive role for Six1 during muscle development in vivo (Laclef et al. 2003). 
Myogenesis is also regulated by negative factors. One of these negative regulatory 
factor is BMP4, that inhibits the expression of MyoD in the somite. More recently, BMP4-
mediated inhibition has been shown to be antagonized in the medial somite by Noggin, 
which is induced by Wnt and Shh (Hirsinger et al. 1997; McMahon et al. 1998).  
All together these signals play a coordinated action that lead to the formation of 
skeletal muscle (Fig. 1). After the first phase of proliferation and migration, and a second 
phase of differentiation, finally, mononucleated myocytes specifically fuse to each other to 
form multinucleated syncytium, which mature into contracting muscle fibers. During the 
course of muscle development, a distinct subpopulation of myoblasts fails to differentiate, 
but remains associated with the surface of the developing myofiber as quiescent muscle 
satellite cells. 
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Muscular stem cells 
 
Almost 50 years ago, Alex Mauro observed, by electron microscopy, the presence of 
mononucleated cells, which he termed “satellite cells”, that were intimately associated with 
skeletal muscle fibers of the frog (MAURO 1961), between the muscle fiber membrane and 
the basal lamina, which is a component of the extracellular matrix. Satellite cells are rare in 
uninjured muscles, typically accounting for <2% of the nuclear content of muscle, but their 
remarkable proliferative potential confer them the property to repair the skeletal muscular 
damage (Zammit et al. 2002). Several studies strongly suggest a correlation among satellite 
cells, microvasculature and endothelial cells during myogenesis. Infact, the 
microvasculature seems to play a major role. In humans and mice, respectively 68% and 
82% of the satellite cells are located within 5mm from neighboring capillaries or vascular 
endothelial cells. (Christov et al. 2007). In addition, there is also correlation between the 
number of capillaries per muscle fiber and the number of satellite cells (Christov et al. 
2007). 
Satellite cells are normally quiescent, but become activated in response to injury, 
proliferate, differentiate, and fuse to repair or replace damaged myofibers. In these processes 
the stem cell niche, growth factors, cytokines, and neurotrophic factors play a prominent 
role. The niche is commonly defined the place where stem cells can reside for an indefinite 
period of time and produce progeny cells while self-renewing (Ohlstein et al. 2004). It has 
Fig.1 
Schematic representation of regulatory network controlling the development of skeletal 
muscle. 
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been shown, that mechanical, electrical and chemical signals are involved in satellite cell 
regulation (Charge and Rudnicki 2004; Kuang et al. 2008). 
A growing body of evidence suggests that multiple, distinct populations of satellite 
cells reside in adult muscle (Bischoff 1986; Goldring et al. 2002; Hawke and Garry 2001; 
Schmalbruch and Lewis 2000; Seale and Rudnicki 2000; Zammit and Beauchamp 2001) and 
this existence of multiple populations of myogenic precursor cells allow muscle tissue to 
respond differentially to a particular stimulus, type of injury, or physiological demand, and 
thereby enable a highly controlled response.  
Different muscles exhibit distinct characteristics, including anatomical structure, 
contractile and metabolic properties, fiber composition, blood supply, pattern of innervation 
and embryonic origin. So, they have different regenerative capacities (Pavlath et al. 1998) 
and are differentially affected in genetic disorders (Emery 2002). One difference is the 
number or density of the satellite cells expressed by different muscle groups. Beyond the 
simple property of number or density, evidence suggests that satellite cells resident in 
different muscle compartments are not identical but differ in terms of embryonic origin, 
lineage history, gene expression pattern and functional behavior in vitro and in vivo. 
Moreover, several differences in satellite cells associated with fast or slow fibers/muscles 
have been reported, including differences in the proliferation rate and differentiation 
capacity of their progeny in culture (Barjot et al. 1995; Lagord et al. 1998). Myoblasts from 
fast or slow muscles differ in the levels of expression of many genes, such as AChE (Barjot 
et al. 1993), FGF-receptors (Martelly et al. 2000), and Pax7 (Brzoska et al. 2009).  
The hypothesis that satellite cells are heterogeneous in terms of self-renewal is also 
supported by evidence from transplantation experiments. Only a small subpopulation of 
cultured myoblasts was shown to efficiently survive transplantation and contribute to 
regeneration, exhibiting stem cell-like properties (Beauchamp et al. 1999). The finding 
suggests that an altered environment may select specific subpopulations of satellite cells 
with different self-renewing ability (Heslop et al. 2000). 
A recent research also suggests that other precursor cells might play a role in skeletal 
muscle regeneration (Charge and Rudnicki 2004; Peault et al. 2007). These cells can be 
divided into mesoangioblasts (vessel-associated stem cells), side population cells (SP), 
muscle-derived stem cells (MDSCs), pericytes, and CD133+ stem cells (Dellavalle et al. 
2007; Asakura et al. 2002; Torrente et al. 2004; Galvez et al. 2006; Peault et al. 2007; 
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Negroni et al. 2009), and into muscle- and non muscle-derived stem cells (Cao and Huard 
2004).  
Mesoangioblasts are multipotent progenitors of mesodermal tissues, physically 
associated with the embryonic dorsal aorta in avian and mammalian species. Early studies 
concerning the capacity of mesoangioblasts to differentiate in various mesodermal 
phenotypes qualified these progenitors as a novel class of stem cells (Cossu and Bianco 
2003). Other studies show that it is possible to transplant mesoangioblasts into dystrophic 
dogs and obtain an extensive reconstitution of fibers expressing dystrophin, an improvement 
in the contraction force and, in many cases, a preservation of walking ability (Sampaolesi et 
al. 2006). 
Pericytes seem to be progenitor cells for mesenchymal cells, such as osteoblasts and 
adipocytes, and wrap around the vascular tube and interdigitate with the endothelial cells in 
the basement membrane of the vessels, playing a fundamental role in the maintenance of 
microcirculation functionality. Some studies demonstrated that pericytes had an high 
capacity of myogenic differentiation because they gave rise to a high number of muscular 
fibres when injected into scid/mdx mice (Dellavalle et al. 2007). Moreover it has been 
proposed that the pericyte could be released from its position on a vascular tube in the case 
of a focal injury, functioning as immunomodulatory and trophic mesenchymal stem cell 
(Caplan 2008; Morgan and Muntoni 2007). 
CD133+ cells are considered to be haematopoietic and endothelial stem cells of bone 
marrow origin, that could give rise to both endothelial cells and myoblasts (Peault et al. 
2007). It has been demonstrated the stemness of circulating human CD133+ cells and their 
ability to restore dystrophin expression and eventually regenerate the satellite cells pool in 
dystrophic mouse after intra-muscular and intra-arterial delivery (Gavina et al. 2006). 
SP cells in the bone marrow of adult mice are primarily CD34-, and are highly 
enriched in their hematopoietic content (Goodell et al. 1997). It is possible that these cells 
originate from multipotent mesenchymal stem cells in the bone marrow stroma to give rise 
to bone, cartilage, and connective tissue (Pereira et al. 1995). A particular subpopulation of 
SP cells was found in the muscle and after transplantation, these cells were able to 
participate in the formation of skeletal myotubes during regeneration (Gussoni et al. 1999). 
This population of a multipotent muscle-derived stem cell (MDSC) resides within skeletal 
muscle and has  the ability to self renew and to differentiate into other mesodermal cell 
types (Sarig et al. 2006; Tamaki et al. 2007). Other studies demonstrated that this population 
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is distinct from satellite cells (Asakura and Rudnicki 2002; Qu-Petersen et al. 2002) and that 
they can preserve their myogenic potential in vitro even after differentiation into other 
lineages, such as haematopoietic differentiation, if the appropriate stimulus is given 
(Negroni et al. 2006). 
In summary, many different populations of stem cells might be involved in muscle 
regeneration, and potentially they can be used in the treatment of diseased skeletal muscle.  
 
 
Connexins (CXs) and GAP junctions in skeletal muscle 
 
Gap junction (Fig.2) are specialized membrane regions composed of aggregates of 
transmembrane channels that directly connect the cytoplasm of adjacent cells, and that allow 
intercellular movement of ions, metabolites and second messengers (Bruzzone et al. 1996). 
Each intercellular channel is formed by the conjunction of two hemichannels, or connexons, 
formed by exameric assembly of subunit protein, called connexins and are characterized by 
two distinct properties, their conductivity (i.e. permeation of small ions) and their 
permeability to larger molecules. Gap junction channels are gated by chemicals (including 
pH) and by membrane potential. Each connexin consists of four α-helical transmembrane 
domains, two extracellular loops, a cytoplasmic loop, a cytoplasmic aminoterminal and 
carboxy-terminal domains. Connexins are synthesized in the endoplasmic reticulum and 
oligomerize in the ER⁄Golgi or trans-Golgi network to form hexameric hemichannels or 
connexons (Koval 2006). Connexons are subsequently transported to the plasma membrane 
by vesicular carriers, travelling along microtubules. When two cells are closely apposed, 
connexons from one cell can dock with their counterparts in the neighboring cell and form a 
gap junction channel. Depending on the cell type and the connexin expressed, connexons 
can function as hemichannels, providing a pathway for transmembrane signalling, whereas 
gap junction channels will enable a direct communication pathway between the cytoplasms 
of adjacent cells. This type of intercellular communication permits coordinated cellular 
activity, a critical feature for organ homeostasis during development and adult life of 
multicellular organisms.  
Gap junctions participate in the regulation of diverse functions, including contraction 
of cardiac and smooth muscle (Huizinga et al. 1992; Page and Shibata 1981; Miller et al. 
1989; Spray and Burt 1990; De Mello 1994), transmission of neuronal signals at electrotonic 
synapses (FURSHPAN and POTTER 1959; Auerbach and Bennett 1969; Sotelo and Llinas 
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1972; Bennett and Verselis 1992), and metabolic cooperation in development and vascular 
organs (Larsen and Wert 1988; Goodenough 1992). Permeability of intercellular channels to 
second messengers may also regulate secretion by both the exocrine and endocrine pancreas 
(Bruzzone and Meda 1988; Serre-Beinier et al. 2000) and plays a critical role in pattern 
formation during development (Caveney 1985; Guthrie and Gilula 1989; Kidder 1992).  
The connexin gene family comprises 20 members in the mouse and 21 members in the 
human genome, 19 of which can be grouped as sequence-orthologous pairs (Koval 2006). 
Connexin are commonly named according to their molecular weight (for instance, Cx43 has 
a mobility of 43 kDa), and their genes have been classified into 4–5 groups (based on 
sequence homology). Each connexin have distinct expression patterns and regulation 
properties. Nine of these connexins are expressed in the brain, but only Cx36 (Condorelli et 
al. 2000) and Cx45 are expressed in the neurons. These two connexin are largely expressed 
during embryogenesis and their expression persist, also during postnatal life, in the specific 
region of the central nevous system. After the birth Cx36 remain express in many brain area 
and in particular in the inferior olive and the olfactory bulb (Belluardo et al. 2000). The 
Cx45, instead, is highly expressed during embryogenesis and up to 2 weeks after birth in 
nearly all brain regions. Afterward its expression is restricted to the thalamus, the CA3 
Fig.2 
Structure of gap junction channels.  
 
9 
Dott.ssa M. Frinchi 
region of hippocampus and the cerebellum (Maxeiner et al. 2003). The other connexins 
present in the nervous system are instead exclusively expressed in the glial cells (Condorelli 
et al. 2003). 
Gap junctions are found in virtually all mammalian tissues with the notable exception 
of adult skeletal muscle, although they have been detected in early developing muscle tissue 
(Schmalbruch 1982; Balogh et al. 1993). This characteristic is due to the intrinsic property 
of the skeletal muscle. The muscular fibers, infact, must be electrically isolated from each 
other to prevent the spread of the depolarization current. Myogenic progenitor cells have 
been shown to adhere and fuse in a highly coordinated way and to form gap junctions, 
suggesting a role for these channels in early muscle differentiation (Constantin and Cronier 
2000). Gap junctions, infact, have been found in embryonic and newborn skeletal muscles of 
the chick, mouse, and the rat (Dahl et al. 1995; Schmalbruch 1982). The importance of 
intercellular gap junctional communication for myogenesis is also supported by a study by 
Proulx et al. (1997) showing that after application of pharmacological gap junction blockers, 
myoblasts do not express myogenin or MRF4, both markers of terminal differentiation.  
During embryonic development gap junctions have been described among myoblasts, 
as well as among myoblasts and myotubes, by electron microscopy (von Maltzahn  and 
Willecke 2005). The corresponding connexin proteins are Cx39, Cx40, Cx43 and Cx45(von 
Maltzahn  et al. 2004; Belluardo et al. 2005; Araya et al. 2005; Trovato-Salinaro et al. 
2009). In myoblasts, Cx43 expression is predominant and a prerequisite for their fusion 
(Squecco et al. 2006). It is expressed first at embryonic stage of 11 days in somite of the 
dermnomyotome. Then Cx43 is expressed in many cell clusters and their expression varies 
in dependence on the muscles type. At embryonic stage of 18 days, when the myotube is 
completely formed, connexin 43 expression  is restricted to a scattered cells along the 
myotube of new formation. Cx45, instead, is largely expressed in many cell of skeletal 
muscle in the early stage of the myogenesis, then its expression decrease, and after the bird 
it is limited to a cell along the myotube, probably satellite cells. The distinct time course of 
connexon expression is important for proper differentiation of skeletal muscle, e.g. 
overexpression of Cx43 in cultured mouse myotubes, under control of a constitutive active 
viral promoter, led to significant cell death upon differentiation (Reinecke et al. 2004). 
The Cx39 gene is localized on chromosome 17 (cytogenetic band q12.1) and has a 
high level of similarity with other connexins in the extracellular loops, in the aminoterminal 
domain, and in the transmembrane domains. The Cx39 is expressed both in embryonic 
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development and in adult life during the process of skeletal muscle regeneration following 
muscle injury (Belluardo et al. 2005; von Maltzahn  et al. 2004). The first signal of Cx39 
mRNA expression was observed at E12, at the myotome level. At E16, Cx39 mRNA was 
expressed in all the developing skeletal muscles, but at E20, Cx39 expression decreased in 
several muscles and disappeared within the first week of postnatal life (Belluardo et al. 
2005), suggesting that this connexin is not involved in the process of postnatal growth of the 
muscle mass. Our studies also show that this connexin is expressed in regenerating adult 
skeletal muscle after crush injury, and that its expression is restricted, like during 
myogenesis, to myogenin positive cells (Belluardo et al. 2005). The great intrinsic interest 
of these results derives from the conclusion that Cx39 is selectively and transiently 
expressed in cells of the myogenic lineage during skeletal myofiber generation in the 
embryo and myofiber regeneration in the adult. A very recent study showed that in Cx39 
deficient mice skeletal muscles develop regularly and the myogenesis, like regeneration 
process, is not compromised (von Maltzahn  et al, in press). However, Cx39 deficient mice 
display an earlier onset of markers of differentiation, e.g. MyoD and myogenin compared to 
control littermates. This earlier onset of differentiation is accompanied by an increased 
expression of Cx43, suggesting that Cx43 may compensate for the loss of Cx39 during 
myogenesis and regeneration processes (von Maltzahn  et al, in press) 
 
Skeletal muscle regeneration following injury 
 
The basic contractile unit of skeletal muscle is the muscle fiber; thousands of muscle 
fibers form together an individual skeletal muscle. Muscle fibers are limited by a plasma 
membrane (sarcolemma) surrounded by a basal lamina, and outside of this, a connective 
tissue composed by scarce extra cellular matrix proteins, capillaries and nerve terminals 
(Buckingham 2001). The adult skeletal muscle is a highly dynamic tissue that is capable of 
regeneration following exercise-, immobilization- or chemically-induced damage. In 
response to exogenous stimuli or to biological factors, the muscle is able to adapt by 
increasing the size and amount of contractile proteins. This leads to increase in fiber size and 
their consequent force production. Muscle remodeling occurs throughout the entire life 
although at different rate considering the developmental stages. This dynamic property is 
due to satellite cells that are located, as mentioned above, between the basal lamina and the 
fiber sarcolemma. The satellite cells also confer to skeletal muscle the important property of 
regeneration in consequent to a muscle damage. 
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Skeletal muscle regeneration is a complex process, which is not yet completely 
understood. In human and animal models, increased serum creatine kinase is observed after 
mechanical stress (e.g., extensive physical exercises) and in the course of muscle 
degenerative diseases, such as muscular dystrophies (Coulton et al. 1988; Nicholson et al. 
1979; Percy et al. 1979; Armstrong et al. 1991; LeBlanc et al. 1993; Sorichter et al. 2001; 
Zatz et al. 1991). It has been hypothesized that increased calcium influx after sarcolemmal 
or sarcoplasmic reticulum damage results in a loss of calcium homeostasis and increased 
calcium-dependent proteolysis, that drive tissue degeneration (Alderton and Steinhardt 
2000; Armstrong 1990; Belcastro et al. 1998). Thus disrupted myofibers undergo focal or 
total autolysis, depending on the extent of the injury. The healing of skeletal muscle in 
response to trauma, infact,  depends on the type of injury such as contusion, strain, and 
laceration, and on the severity. However, in general, the healing process consists of three 
phases: the destruction phase, the repair phase, and the remodeling phase (Huard et al. 2002; 
Charge and Rudnicki 2004; Jarvinen et al. 2005; Grefte et al. 2007). 
The destruction phase is characterized by necrosis, hematoma formation, and the 
influx of inflammatory cells. The activated immune cells also produce adhesion molecules, 
such as selectins (Lasky 1995) and cytokines, such as IL-6 and TNF-α. The inflammatory 
reaction influences the local blood flow and vascular permeability, which accelerates the 
immune response (Huard et al. 2002; Boonen and Post 2008). 
As a result of skeletal damage, inflammatory cells, residing within the muscle, release 
factors which in turn provide the chemotactic signals to circulating inflammatory cells. 
Neutrophils are the first inflammatory cells to invade the injured muscle, with a significant 
increase in their number being observed as early as 1-6h after the damage (Fielding et al. 
1993; Orimo et al. 1991). After neutrophil infiltration and 48h postinjury, macrophages 
become the predominant inflammatory cell type within the site of injury (Tidball 1995). 
Recent studies showed that macrophages, which are attracted upon injury, play a 
crucial role in skeletal muscle regeneration. During the repair phase, the macrophages 
phagocyte the necrotic debris, and regeneration of myofibers occurs through the action of 
satellite cells (Wozniak et al. 2005; Zammit et al. 2006). Different stimuli have been 
proposed as initiators of satellite cell activation; extracts from the injured fibers, molecules 
released by the invading macrophages, and soluble factors from connective tissue have all 
been proposed (Lescaudron et al. 1999). After their activation, quiescent satellite cells 
expressing Pax7 migrate to the site of injury, up-regulate the MRFs, MyoD and Myf5, and 
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become proliferative myoblasts (Smith et al. 1994; Yablonka-Reuveni and Rivera 1994; 
Cornelison and Wold 1997; Cooper et al. 1999; Beauchamp et al. 2000). Subsequent 
differentiation of the myoblasts is marked by the down-regulation of Pax7 (Olguin and 
Olwin 2004; Zammit et al. 2004) and up-regulation of the MRF4 and Myogenin (Smith et 
al. 1994; Yablonka-Reuveni and Rivera 1994; Cornelison and Wold 1997). Ultimately, 
these differentiated myoblasts form new multinucleated myofibers (hyperplasia), or fuse to 
damaged myofibers for muscle regeneration or for muscle hypertrophy process (Hawke and 
Garry 2001; Charge and Rudnicki 2004). At the end of the regeneration process, the 
contractile system is perfectly reconstructed, innervated and perfused. 
In vivo, macrophage suppression leads to incomplete skeletal muscle regeneration 
(Segawa et al. 2008). Furthermore, the prevention of monocyte recruitment to the site of 
injury completely inhibits skeletal muscle regeneration (Arnold et al. 2007). Malerba (2009) 
and Segawa (2008) suggest that macrophages directly affect satellite cells by two different 
mechanisms (Chazaud et al. 2009). First, the macrophages can secrete soluble factors 
affecting satellite cells, and second, macrophages can interact with satellite cells by cell–cell 
contact, and thereby protect them from apoptosis (Chazaud et al. 2003). However, 
macrophages play a dual role depending on their activity (Arnold et al. 2007; Chazaud et al. 
2009; Villalta et al. 2009). Pro-inflammatory macrophages induce myogenic precursor cell 
proliferation, while anti-inflammatory macrophages induce differentiation and fusion of 
these cells (Villalta et al. 2009). A switch between the pro- and anti-inflammatory 
macrophages has been observed in vivo after injury, and during the course of muscular 
dystrophy (Villalta et al. 2009; Arnold et al. 2007). Depletion of the anti-inflammatory 
macrophages reduces the diameter of regenerating myofibers (Chazaud et al. 2009). 
Other important factors involved in the regulation of satellite cells are the cell-cell 
interaction and the communication with extracellular matrix. The basal side of the satellite 
cells expresses integrin α7β1, which links the cytoskeleton with laminin in the basal 
membrane (Song et al. 1992; Burkin and Kaufman 1999). Integrin α7β1 plays a major role 
in the transduction of strain-induced mechanical forces into chemical signals, which are 
involved in the regulation of myogenesis (Boppart et al. 2006). A recent study showed that 
integrin α7β1 is required for satellite cell migration and that hepatocyte growth factor (HGF) 
plays a crucial role in the guidance of satellite cells. Furthermore, the results suggests that 
unrelated and divided satellite cells stay in long contact with each other and co-migrate 
along the myofiber (Siegel et al. 2009). The apical side expresses M-cadherin that attaches 
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the satellite cell to the adjacent myofiber (Cornelison and Wold 1997; Kuang et al. 2008). 
Both attachment sites are essential for signal transduction between the satellite cell and the 
two flanking structures (Cornelison and Wold 1997; Burkin and Kaufman 1999). In 
addition, it has been suggested that M-cadherin plays a significant role in the attachment and 
fusion of myoblasts to form new and regenerate damaged myotubes (Cifuentes-Diaz et al. 
1995). This is supported by a significant increase of M-cadherin in activated satellite cells 
during skeletal muscle regeneration (Irintchev et al. 1994). 
Growth factors also are crucial in satellite cell regulation, since they can activate 
intracellular signaling pathways (Charge and Rudnicki 2004; Philippou et al. 2007), 
regulating muscle-specific genes (Hawke and Garry 2001; Charge and Rudnicki 2004).  
These growth factors secreted by macrophages and T-cell , together with the growth factors 
released from the extracellular matrix, attract and activate the satellite cells and induce cell 
differentiation (Huard et al. 2002; Grefte et al. 2007). Many growth factors, such as HGF, 
FGF-2 and -6, vascular endothelial growth factor (VEGF), platelet-derived growth factor-
AA and -BB (PDGF-AA and -BB), stromal derived factor-1 (SDF-1) and IGF-1 and -2 play 
a major role in myogenic proliferation and differentiation (Doumit et al. 1993; Robertson et 
al. 1993; Allen et al. 1995; Haugk et al. 1995; Hawke and Garry 2001; Ratajczak et al. 
2003; Charge and Rudnicki 2004; Boonen and Post 2008). In particular IGF-1 is critical for 
skeletal muscle growth (Menetrey et al. 2000; Sato et al. 2003). In vitro, IGF-1, and in a 
later phase IGF-2, are both able to alter the expression of myogenic regulatory factors and 
promote the proliferation and the differentiation of SC-derived myoblasts (Allen and 
Boxhorn 1989; Charge and Rudnicki 2004). Besides IGF-1, also HGF and VEGF are 
involved (Huard et al. 2002). HGF is the primary factor to induce satellite cell proliferation 
by binding to c-met (Allen et al. 1995; Gal-Levi et al. 1998; Tatsumi et al. 1998). 
Correlating with this property, HGF expression is increased in proportion with the degree of 
injury, during the early proliferation phase of muscle regeneration (Tatsumi et al. 1998; 
Suzuki et al. 2002; Tatsumi et al. 2001). In addition, HGF plays a role in the migration of 
satellite cells to the site of injury (Bischoff 1997; Suzuki et al. 2000). VEGF can improve 
muscle healing by stimulating angiogenesis to increase the nutrient and oxygen supply, 
which is essential for the healing process (Springer et al. 1998; Gowdak et al. 2000). FGF-6 
expression, for example, is muscle specific and is up-regulated during muscle regeneration 
(Delapeyriere et al. 1993).  
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From a morphological point of view, after a skeletal damage, in the injuried area  the 
first three days is caractherized by an accumulation of different cell populations that include, 
inflammatory cells and satellite cells. Then myoblast cells start to fuse each other to form 
new myotube. From the fifth day, along edge of damaged area it possible to see cellular 
aggregate or myotube caractherized by a central nucleus. In the next days the numbers of 
myotube increase and progressively the tissue appears completely reconstructed and it 
possible to see only a number of myofibers with central nuclei. 
 
 
 
Muscular dystrophy  and therapeutic strategies 
 
Duchenne’s muscular dystrophy (DMD) is a lethal X-linked myopathy characterized 
by the near absence of dystrophin protein in skeletal muscles. Dystrophin is a cytoskeletal 
protein connecting the cytoskeletal actin network to a complex of proteins in the membrane 
(dystrophin- associated complex, DAC), which further connect to the extracellular matrix by 
laminin. In DMD, not only dystrophin is generally absent, but the expression of the DAC 
proteins is greatly reduced (Ervasti and Campbell 1991). It appears that the presence of 
dystrophin is necessary for the stability of this protein complex. Loss of dystrophin renders 
multinucleated skeletal muscle cells, known as myofibers, susceptible to exercise induced 
injury. 
Muscle histology in DMD patients is almost normal before the onset of clinical 
symptoms at 3–5 years of age. The preliminary stage of the disease is characterized by the 
presence of focal groups of necrotic myofibres, muscle hypertrophy and abnormally high 
levels of muscle creatine kinase. In the second phase, repeated cycles of degeneration 
exhaust the regenerative capacity of muscle-specific stem cells and fibrotic mechanisms 
cause the progressive replacement of contractile muscle tissue with collagenous connective 
tissue (Deconinck and Dan 2007; Zhou and Lu 2010). This process leads to joint 
contractures, loss of ambulation by 10–12 years and death following respiratory or cardiac 
failure (Wells and Wells 2002). 
Several different therapeutic strategies have been pursued. The most perfect solution 
would be to place a normal copy of the dystrophin gene into muscle cells, and hence restore 
sufficient protein expression to improve structure and function, as successful therapy would 
require massive and sustained gene transfer, this is a daunting task (Thioudellet et al. 2002). 
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Nevertheless, the availability of high-efficiency viral infection (Roberts et al. 2002; Scott et 
al. 2002; Cerletti et al. 2003) and nonviral transfection (Thioudellet et al. 2002; Gollins et 
al. 2003; Lu et al. 2003) methods and the development of functional mini-dystrophin genes 
still allow it as a possibility (Thioudellet et al. 2002; Wells and Wells 2002). Transplantation 
of normal donor (or genetically corrected host) muscle precursor cells (myoblast transfer) 
has also been explored as a method for restoring dystrophin protein to dystrophic muscle. 
Transplanted muscle precursors can differentiate to form dystrophin expressing muscle 
(Law et al. 1988; Partridge et al. 1989; Morgan et al. 1990). This technique is still 
constrained by the difficulties associated with treating large volumes of muscle with long-
lasting effect. Other strategy includes implementation of exercise programme. In this context 
various exercise regimes have been used in attempt to improve muscle function and the mdx 
mice have been used to assay the effects of different exercise programme on function and 
morphology of dystrophic muscle. While models of excessive or otherwise inappropriate 
activity may induce muscle damage and increase pathology in mdx mice (Brussee et al. 
1997; De et al. 2003; Okano et al. 2005), low intensity or voluntary exercise may improve 
muscle pathology. Beneficial effects of regular exercise on dystrophic mdx muscle are 
reported for free wheel running (Dupont-Versteegden et al. 1994; Hayes and Williams 1996; 
Carter et al. 1995), swimming, and low-intensity endurance exercise (Hayes and Williams 
1998). However, these discrepancies in the literature about the appropriate beneficial 
exercise in dystrophic muscle may be explained by differences in experimental procedures: 
duration, intensity and type of exercise, variations in age of mdx mice, different 
environmental conditions. 
The most commonly laboratory model used of DMD is the C57Bl/10ScSn mdx (mdx) 
mouse (Bulfield et al. 1984). Muscle pathology is comparatively moderate and mechanical 
function is less seriously compromised, resulting in an almost normal lifespan. Muscle 
pathology is most pronounced in the mdx between 2 and 8weeks of age, a period 
characterized by the presence of necrotic foci, newly regenerated centrally nucleated 
myofibres and high plasma concentrations of creatine kinase. Detailed analysis of mdx 
muscle pathology has shown that whilst some muscles (such as the masseter) are spared, 
others (such as the gastrocnemius and in particular, the diaphragm) are severely affected 
(Muller et al. 2001). Currently, the only treatment to prove clinically efficacious is dosage 
with the steroid drug prednisone/prednisolone, which results in a modest increase in strength 
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and delays, but does not halt, the progress of the disease (Backman and Henriksson 1995; 
Dubowitz et al. 2002).  
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AIMS 
 
 
 
Aim I 
 
Generally, muscle regeneration may be dependent on myoblasts fusing to existing 
damaged myofibers (myoblast/myofiber fusion), or on myoblasts that fuse with other 
myoblasts forming myotubes (myoblast/myoblast fusion). At present, we do not know which 
signals during muscle regeneration promote fusion of myoblasts to a preexisting myofiber or 
rather induce formation of a new myofiber. In this context, recent data have shown a 
relevant role of gap junctions as cell-cell communication and functional synchronization 
before myoblast fusion (Araya et al. 2005; Belluardo et al. 2005; von Maltzahn  et al. 2004).  
Myogenic progenitor cells have been shown to adhere and fuse in a highly coordinated 
way and to form gap junctions, suggesting a role for these channels in early muscle 
differentiation (Constantin and Cronier 2000). Gap junctions have been found in embryonic 
and newborn skeletal muscles of the chick, mouse, and the rat (Dahl et al. 1995; 
Schmalbruch 1982). Cx43 and Cx40 have been described in myoblasts of differentiating 
skeletal muscles, and evidence in favor of a functional role of Cx43 in the differentiation 
and fusion of myoblasts has been reported by Dahl et al. (Dahl et al. 1995). Recently, Cx39 
has been found to be expressed during skeletal muscle embryonic development and involved 
in the myoblast fusion (Araya et al. 2005; Belluardo et al. 2005; von Maltzahn  et al. 2004). 
Indeed, following the chemical block of gap junctions or after deletion of the Cx43 gene, 
cultured myoblasts do not fuse with each other and do not express specific genes for cellular 
differentiation, such as myogenin (Constantin and Cronier 2000; Schmalbruch 1982). 
Moreover, in regenerating skeletal muscle, a transient upregulation of Cx45, Cx43, and 
Cx39 expression precedes myoblast fusion (Araya et al. 2005; Belluardo et al. 2005; von 
Maltzahn  et al. 2004). Using knockout mice, it has been evidenced that Cx43 is required for 
normal myogenesis in vitro and adult muscle regeneration in vivo (Araya et al. 2005). 
A comparative in vivo study of several Cxs in the same model of adult muscle injury 
provides fundamental information to understand the regulation and role of Cxs in committed 
myogenic cells during muscle regeneration. To this end, in this study, we analyzed, using in 
situ hybridization and immunohistochemistry, the spatial and temporal expression pattern of 
several Cxs (Cx30 Cx37, Cx39, Cx40, Cx43, and Cx45) during adult skeletal muscle 
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regeneration in response to crush injury. Such mechanical lesion by disruption of myofiber 
integrity promotes the activation of satellite cells to proliferate and perform both myogenesis 
and repair of injured skeletal fibers (Schultz and McCormick 1994; Bassaglia and Gautron 
1995; Charge and Rudnicki 2004; Creuzet et al. 1998; Pavlath et al. 1998; Saito and Nonaka 
1994).  
 
 
Aim II 
 
In patients with Duchenne muscular dystrophy, muscle biopsy characteristically 
demonstrates areas of necrotic or degenerating muscle fibers, often observed in clusters 
surrounded by macrophages and lymphocytes, and areas with small immature centrally 
nucleated fibers reflecting muscle regeneration from myoblasts, that results in a balance 
between necrotic and regenerative processes. (Brunelli et al. 2007; Grounds and Torrisi 
2004; Hodgetts et al. 2006; Radley et al. 2007; Spencer and Tidball 2001). 
Various strategy have been proposed in order to reduce the muscle wasting associate 
to muscular dystrophy, such as replacement of functional dystrophin by genetic, cell 
transplantation or molecular interventions (Odom et al. 2007), including implementation of 
exercise programme. In this context, as above mentioned, voluntary exercise such as free 
wheel running (Dupont-Versteegden et al. 1994; Hayes and Williams 1996; Carter et al. 
1995) and swimming or low-intensity endurance exercise (Hayes and Williams 1998). 
In the present study we designed appropriate exercise parameters that do not worsen 
the dystrophic condition, namely a low-intensity endurance exercise that consists of  
exercise bouts performed daily five times per week for a total time period of four weeks at 
progressively increasing loads (increasing running distance) on a motorized Rotarod. 
The aim of this study was to test if a new programmed low-intensity endurance 
exercise may positively affects the degeneration/regeneration process in dystrophic muscle 
of mdx mice, and may have beneficial effects on dystrophic muscle function, such as fatigue 
resistance and improvements in strength. 
Additionally, in the present study, we evaluated and quantified for the first time the 
regeneration process in the dystrophic muscle of sedentary and exercised mdx mice by 
monitoring the expression of connexin-39, a specific gene involved in skeletal muscle 
regeneration process (Belluardo et al. 2005).  
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MATERIALS AND METHODS 
 
 
 
Animals  
 
The present study was performed on adult male Wistar rats (350 g body wt) housed 
under alternating 12h periods of light and darkness, in a temperature-controlled (24 2°C) and 
humidity controlled room and male Wild-type (C57BL/10ScSn from Harlan Italy), male 
mdx (C57BL/10ScSn-Dmdmdx/J from Jackson Laboratories) and male C57/BL6 (from local 
stock) adult mice. The mice were kept under environmentally controlled conditions, ambient 
temperature 24 °C, humidity 40% and 12h light/dark cycle, with food and water ad libitum. 
Procedures involving animals and their care were conducted in conformity with the 
institutional guidelines that are in compliance with national (D.L. no. 116, G.U., suppl. 40, 
February 18, 1992) and international laws and policies [European Economic Community 
Council Directive 86/609, OJ L 358, 1, December 12, 1987; National Institutes of Health 
(NIH) Guide for the Care and Use of Laboratory Animals, NIH Publication no. 80–23, 1985, 
and Guidelines for the Use of Animals in Biomedical Research, Thromb Haemost 58: 1078–
1084, 1987]. All efforts were made to minimize the number of animals used and all 
experiments were approved by the local ethical committee. 
 
 
Animal model of muscle regeneration after injury 
 
Adult males rats and adult C57/BL6 male mice were used for gastrocnemius crush 
injury of right leg. Gastrocnemius crush injury was achieved under chloral hydrate 
anesthesia (350 mg/kg intraperitoneally). After skin incision, the right gastrocnemius muscle 
was exposed, the middle part was crushed with a hemostat clamp closed for 3 s, and the skin 
was then sutured. The trauma was standardized by using the same muscle level and the same 
strength to crush the muscle by closing the hemostat clamp. In some rats, the soleus or 
extensor digitorum longus muscles were crushed. The rats and mice were sacrificed by 
excess anesthesia, in groups of three at various time points following injury. The injured 
muscle was dissected, frozen in precooled isopentane, and stored at 70°C. Cryosections were 
prepared from the mouse muscles in which, under stereomicroscopy, the lesioned area was 
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dissected and tissue was used for the detection of Cx39 protein levels by western blotting. 
The rat injured muscles were used for in situ hybridization and immunohistochemical 
analysis. 
 
Riboprobes labeling 
 
The in situ hybridization procedure was used to examine the spatial and temporal 
expression pattern of Cx mRNAs in adult regenerating skeletal muscle. The following 
riboprobes were used: for Cx30 riboprobe, a 360-bp fragment encompassing nucleotides 
772-1131 in the Cx30 sequence (GenBank access no. Z70023), subcloned in pCR-Script 
SK(+) (Stratagene, La Jolla, CA), linearized with SacI, and transcribed with T7 RNA 
polymerase for the antisense probe, or with EcoRI and transcribed with T3 RNA polymerase 
for the sense probe; for Cx39 riboprobe, a 298-bp fragment encompassing nucleotides 560-
859 70-367 in the Cx39 sequence (GenBank access no. X51615), subcloned in pCR-Script 
SK(+) (Stratagene), linearized with SacI, and transcribed with T7 RNA polymerase for the 
antisense probe, or with EcoRI and transcribed with T3 RNA polymerase for the sense 
probe; for Cx40 riboprobe, a 455-bp fragment encompassing nucleotides 262-716 in the 
Cx40 sequence (GenBank access no. AFO21806), subcloned in PCR II TOPO TA 
(Invitrogen, Carlsbad, CA), linearized with EcoRV, and transcribed with SP6 RNA 
polymerase for the antisense probe, or with SacI and transcribed with T7 RNA polymerase 
for the sense probe; for Cx43 riboprobe, a 464-bp fragment encompassing nucleotides 373-
836 in the Cx43 sequence (GenBank access no. M19317), subcloned in pCR-Script SK(+) 
(Stratagene), linearized with EcoRI, and transcribed with T3 RNA polymerase for the 
antisense probe, or with SacI and transcribed with T7 RNA polymerase for the sense probe; 
for Cx45 riboprobe, a 533-bp fragment encompassing nucleotides 625-1157 in the Cx45 
sequence (GenBank access no. X63100), subcloned in pCR-Script SK(+) (Stratagene), 
linearized with SacI, and transcribed with T7 RNA polymerase for the antisense probe, or 
with EcoRI and transcribed with T3 RNA polymerase for the sense probe; for Cx37 
riboprobe, a 464-bp fragment encompassing nucleotides 277-740 in the Cx37 sequence 
(GenBank access no. M76532), subcloned in plasmid vector PCR II TOPO TA cloning 
(Invitrogen), linearized with EcoRV, and transcribed with SP6 RNA polymerase for the 
antisense probe, or with SacI and transcribed with T7 RNA polymerase for the sense probe. 
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The radiolabeling of the riboprobes was performed as previously described in Condorelli et 
al (Condorelli et al. 2003) 
 
 
In situ hybridization 
 
Longitudinal muscle sections (10µm) and whole rat embryonic body, at different 
developmental stages, were cut at -20°C and thawed onto 3-aminopropyl-ethoxysilane-
coated slides. Frozen sections were directly fixed in 4% paraformaldehyde for 1h at 4°C, 
washed in PBS for 15 min, and incubated for 10 min in methanol at 20°C. Subsequently, the 
sections were dried at room temperature for 20 min, rehydrated in PBS for 10 min, and 
processed for the remaining steps of in situ hybridization, as previously described by 
Condorelli et al. (Condorelli et al. 2003). Slides were deproteinated in 0.2M HCl for 10 min, 
acetylated with 0.25% acetic anhydride in 0.1M ethanolamine for 20 min, and dehydrated 
with increasing concentrations of ethanol. Slides were incubated for 16h in a humidified 
chamber at 52°C with 8x105 counts/min probe in 80µl hybridization cocktail (50% 
formamide, 20mM Tris HCl, pH 7.6, 1mM EDTA, pH 8.0, 0.3M NaCl, 0.1M dithiothreitol, 
0.5 g/ml yeast tRNA, 0.1 g/ml poly-A-RNA, 1 Denhardt’s solution, and 10% 
dextransulfate), washed twice in 1 SSC (1 SSC  150mM NaCl, 15mM sodium citrate, pH 
7.0) at 62°C for 15 min, and then in formamide/SSC (1:1) at 62°C for 30 min. After an 
additional wash in 1 SSC at 62°C, single-stranded RNA was digested by RNAse treatment 
(10 g/ml) for 30 min at 37°C in 0.5 M NaCl, 20 mM Tris HCl, pH 7.5, 2mM EDTA. Slides 
were washed twice with 1 SSC at 62°C for 30 min before dehydration in ethanol and air 
drying. Hybridized sections were subsequently coated with Emulsion Type NTB (Kodak, 
catalog no. 8895666) diluted 1:1 in water (Eastman- Kodak, Rochester, NY), and stored in 
desiccated light-tight boxes at 4°C for 4 wk. Slides were developed with D19 (Eastman-
Kodak), fixed with Al-4 (Agfa Gevaert, Kista, Sweden), and counterstained with 
hematoxylin-eosin, rinsed in PBS, dehydrated through graded alcohols, cleared in xylene, 
and coverslipped in DPX mountant. A control of the hybridization specificity of the cRNA 
riboprobes was performed by using sense 35S-labeled riboprobes. 
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In situ hybridization combined with immunohistochemistry 
 
For the colocalization of Cx mRNA expression in myogenic cells, a double-labeling 
was performed by combining in situ hybridization and immunohistochemistry. Frozen 
muscle sections were first processed for the in situ hybridization, as described above, and 
subsequently used for immunohistochemical identification of cells using specific antibodies. 
Immediately after the last wash of the in situ hybridization protocol, the sections were rinsed 
twice in PBS, pH 7.4, for 10 min and subsequently incubated for 20 min in blocking buffer, 
consisting of 2.5% normal goat serum and 0.3% Triton X-100 in PBS, and incubated 
overnight at 4°C in the presence of the primary antibodies, rabbit polyclonal antibody anti-
myogenin diluted 1:200 (M-225 Santa Cruz Biotechnology), or rabbit polyclonal antibody 
anti-M-cadherin diluted 1:250 (H-71 Santa Cruz Biotechnology), or mouse anti-rat integrin-
(M) (CD11b; M1405 Chemicon International) in PBS supplemented with 1.5% blocking 
serum and 0.3% Triton X-100. Sections were then washed three times for 5 min in PBS and 
incubated at room temperature for 1h with a biotinylated anti-rabbit antiserum (Amersham), 
diluted 1:200. After three short washes with PBS, the sections were incubated for 1h with a 
horseradish-peroxidase-streptavidin complex (Vector, Burlingame, CA) diluted 1:100 in 
PBS. After washes in PBS and then in Tris HCl buffer (0.1M, pH 7.4), the peroxidase 
reaction was developed in the same buffer containing 0.05% 3,3-diaminobenzidine-4 HCl 
and 0.003% hydrogen peroxide. After being stained and briefly washed in H2O, the sections 
were dehydrated, coated in NTB emulsion, and processed as described for in situ 
hybridization. 
 
 
Double immunolabeling analysis 
 
Cryostat sections of 10µm thickness of gastrocnemius muscle were thawed onto 3-
aminopropyl-ethoxysilane-coated slides and air dried for 15 min. For Cx detection, the 
sections were then fixed in absolute ethanol for 5 min in RT and rinsed with PBS. After 
preincubation in blocking solution (5% BSA, Triton 0.1% in PBS) for 30 min, the sections 
were incubated overnight at 4°C with either rabbit antiCx39 affinity purified antibodies (von 
Maltzahn  et al. 2004) diluted 1:100 in blocking solution, goat polyclonal anti-Cx37 
antibodies, goat anti-Cx40 antibodies (sc-27715 and sc-20466, Santa Cruz Biotechnology), 
or rabbit polyclonal anti-Cx45 antibodies (sc-25716, Santa Cruz Biotechnology) diluted 
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1:400. After three washing steps with PBS for 5 min, the sections were incubated in RT for 
1h with specific secondary antibodies Cy2 conjugated, diluted 1:200 (711-225-152; Jackson 
Immuno Research Laboratories). Following two washings with PBS, the sections were 
fixed, with exclusion for Cx40 double labeling with Cx39, in 4% paraformaldehyde for 15 
min at 4°C, washed in PBS, and then incubated in blocking solution for 2h in RT with the 
other combination of antibodies for double labeling: the rabbit polyclonal anti-von 
Willebrand factor (vWF), a marker for endothelial cells, diluted 1:300 (sc-14014; Santa 
Cruz Biotechnology). After three washing steps with PBS for 5 min, the sections were 
incubated in RT for 1h with specific secondary antibodies Cy3 conjugated, diluted 1:200 
(705–165-003; Jackson Immuno Research Laboratories). Following two washings with PBS, 
the sections were counterstained by incubation for 10 min with 0.5g/ml of the fluorescent 
nuclear dye Hoechst 33258 (bisbenzimide, Sigma-Aldrich, Germany). Following a short 
washing with PBS, sections were coverslipped in a glycerol-based medium with an anti-
fading agent, and slides were examined under a fluorescence microscope (DMRBE, Leica 
Microsystems). 
 
 
 
In situ hybridization and bromodeoxyuridine immunolabeling 
 
After crush injury, the bromodeoxyuridine (BrdU; 40mg/kg ip) was injected 2, 3, 4, 5, 
and 7 days after injury, and rats were killed following 2h of BrdU injection. The dissected 
gastrocnemius was rapidly frozen and processed first for in situ hybridization, as described 
above, and subsequently for BrdU immunohistochemistry as follows. Muscle sections after 
the in situ hybridization were coated with NTB photoemulsion and exposed for 4 wks before 
being developed for autoradiographic preparation and again fixed in 4% paraformaldehyde 
for 15 min and rinsed twice in Tris-buffered saline (TBS), pH 7.4, for 10 min. Subsequently, 
the sections were incubated, for BrdU immunohistochemistry, with 2N HCl (15 min at 
37°C), and then in borate buffer for 10 min (0.1M, pH 8.5) to stop the reaction. 
Subsequently, the sections were washed and incubated for 15 min in blocking serum and 
0.3% Triton X-100 in TBS, and, after two washes in TBS, were incubated with a mouse 
monoclonal anti-BrdU diluted 1:400 (Roche Mannheim, Germany, product no. 
11170376001) in TBS with blocking serum and 0.3% Triton X-100. After 24h, sections 
were washed 1h in TBS and incubated at room temperature for 1h with a biotinylated 
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universal secondary antibody diluted 1:50 in TBS with blocking serum and 0.3% Triton X-
100. After three 5 min washings with TBS, the sections were incubated for 1h with a 
streptavidin horseradish peroxidase complex (Vector, Burlingame, CA), diluted 1:100 in 
TBS. After washing in TBS and then in Tris HCl buffer (0.1M, pH 7.4) for 10 min, the 
peroxidase reaction was developed in the same buffer containing 0.05% 3,3-
diaminobenzidine-4 HCl and 0.003% hydrogen peroxide. The reaction was stopped in Tris 
HCl buffer and, after dehydration through graded alcohols, cleared in xylene and 
coverslipped with enthelan mountant. The number of BrdU-positive cells was determined by 
counting, in eight sections of each time point examined, with a micrometric quadriculated 
reticulum, five random fields (250-µm2 squares) per section under a light microscope 
(DMRBE, Leica Microsystems). The percentage of double-labeled cells for each Cx 
examined was calculated as mean of percentage obtained in each time point studied. 
 
 
Training protocol 
 
At 10 weeks of age mdx mice were randomly assigned to sedentary (n=17; MDX-SD) 
or trained (n=14; MDX-EX) groups. Similarly, wild type mice were randomly assigned to 
sedentary (n=19; WT-SD) or trained (n=16; WT-EX) groups too. Preliminarily all exercised 
mice underwent a 2-week period of acclimatization trial at very low speed. To avoid the 
confounding effects of the accelerated necrotic stage of the disease present in young mdx 
mice (3-4 weeks of age) and the hormone effects on skeletal muscle typical of pre-
adolescence and puberty in mice (5-7 weeks of age) (Grounds et al. 2008) we tested the 
effects of  low intensity endurance training in adult mice (> 8 weeks of age). Training was 
performed in the same room where the mice were housed using a motorized rotor (Rota-
Rod; Ugo Basile, Biological Research Apparatus, Comerio Varese, Italy). Mice ran 5 
days/week for 4 weeks at progressively increasing loads. Wild-type and mdx mice were 
weighed at the start time of exercise training protocol  and after 2, 3 and  4 weeks of  
training. Mice were still weighed  after the recovery period. 
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Forelimb strength and fatigue 
 
Wild-type and mdx mice were examined for forelimb strength at 1, 3 and 4 weeks of 
training. Briefly, the mouse was placed on a metal grid attached to a force transducer (Grip 
strength meter; Ugo Basile, Biological Research Apparatus, Comerio Varese, Italy), and 
pulled gently from the base of the tail until release. Because the increase in strength 
paralleled somatic growth in normal animals, we analyzed the strength of the mdx and 
controls as a function of weight.  Each mouse underwent five trials and peak grip strength 
was normalized for body weight (force/BW) and recorded as the average of the three best 
efforts divided by the mouse’s body weight. Grip strength fatigue was calculated by 
comparing the first two pulls to the last two pulls (Connolly et al. 2001). The decrement 
between pulls 1 + 2 and pulls 4 + 5 gives a measure of fatigue. In the formula (4 + 5)/(1 + 
2), animals with no fatigue have a value of 1. For convenience, the value resulted from the 
formula above was subtracted from the value of  “1” so that an animal without fatigue has a 
calculated fatigue value of  0, and an animal that can only complete three pulls, because 
completely fatigued, has a value of “1”. The fatigue was expressed as percentage so that a 
value of 0% fatigue would be assigned to mice without fatigue and a value of 100% fatigue 
to mice with complete fatigue.  
 
 
Western blotting analysis 
 
Each experimental group of mice was sacrificed by excess of anesthesia. The 
gastrocnemius and quadriceps muscles were excised under stereomicroscopy, frozen in 
precooled isopentane and stored at –70°C. From these muscles were prepared cryosections 
60 micron used for Cx39 protein levels detection by western blotting. The sampled muscle 
were homogenized in cold buffer containing 50mM Tris–HCl pH 7.4, 150mM NaCl, 1% 
triton, 0.1% SDS, H2O and protease inhibitor cocktail (P8340, Sigma-Aldrich S.r.l., Milan, 
Italy). The homogenate was left on ice for 30 min and then centrifuged at 13,000 rpm for 30 
min at 4°C. The supernatants were stored at −20°C and aliquots were taken for protein 
determination by the method of Lowry et al.(LOWRY et al. 1951). The samples with 30μg 
of protein and mol.wt. markers (161-0375, Bio-Rad Laboratories S.r.l., Segrate (MI), Italy), 
were run on 8% polyacrylamide gel at 100 V and electrophoretically transferred onto 
nitrocellulose membrane (Hybond-C-extra, GE Healthcare, formerly Amersham, Europe 
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GmbH – Filiale Italiana, Milan, Italy). Following 1h of incubation with 5% nonfat milk, the 
membrane was incubated overnight at +4°C with anti-CX39 polyclonal antibody (1:1000) 
raised in rabbit (N-20 Sc-546; Santa Cruz Biotechnology, CA, USA). After washing the 
membrane was incubated for 1h at room temperature with anti-rabbit IgG horseradish 
peroxidase-conjugated diluted 1:5000 (Sc 200 4, Santa Cruz Biotechnology) and CX39 band 
was visualized with chemiluminescence reagent (ECL, GE Healthcare, formerly Amersham, 
Europe GmbH – Filiale Italiana, Milan, Italy) according to the manufacturer's instructions. 
The ECL-films were developed in Kodak D19 developer and fixer (Eastman-Kodak, 
Rochester, NY, USA), and the densitometric evaluation of bands was performed by 
measuring the optical density (O.D.) using NIH ImageJ software and results expressed as 
arbitrary units. 
 
 
Histomorphological analysis 
 
Gastrocnemius or quadriceps longitudinal sections (10μm) were cut at −20°C and 
thawed onto 3-aminopropyl-ethoxysilane-coatedslides. Frozen muscle sections were directly 
fixed in 4% paraformaldehyde and stained with hematoxylin–eosin and then dehydrated 
with ethanol and xylene, mounted with Entellan (Merck, Darmstadt, Germany) and 
examined by lightmicroscopy. 
 
 
Statistical analysis  
Results are reported as mean  SE. Analysis of variance (ANOVA) and Fisher’s PLDS 
correction for post hoc comparison were used to test for differences between sedentary wild 
type (WT-SD), trained wild type (WT-EX), sedentary dystrophic mice (MDX-SD) and 
trained dystrophic mice (MDX-EX) at different time points. Time trends in each group were 
assessed by paired t-test (Statview 5.0.1; SAS Institute, Inc., Cary, NC). Significance was at 
p<0.05.  
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RESULTS 
 
 
 
AIM I 
 
Cxs expression in rat developing skeletal muscle  
 
Autoradiographic film from the in situ hybridization of sagittal sections of whole 
embryonic body revealed intense labeling of Cx39, Cx43 and Cx45 in developing skeletal 
muscle tissue (Fig.3). 
 
 
 
Expression of Cx39 
Cx39 mRNA was detected in limb and trunk muscles, in respiratory muscles 
(including diaphragm), in tongue, in masticatory and facial muscles (including intrinsic and 
extrinsic muscles that drive the vibrissae), and in the muscle group responsible for eye 
movements. The first signal of Cx39 mRNA expression was observed at E12 at the 
myotome level (Fig.4A). At E16, Cx39 mRNA was expressed in all the developing skeletal 
muscles (Fig.4B-F), and the analysis of cresyl-violet-stained sections revealed the presence 
Cx39 
Cx45  sense
Cx43
brain liver 
lung 
vibrissae
Thoracic 
muscles 
diaphragm
Muscles 
of the 
hindlimbs 
Fig.3 
In situ hybridization analysis of Cx39 Cx43 and Cx45 mRNA 
expression during embryonic development . E18 autoradiogram 
showing Cx39, Cx43 and Cx45 mRNA expression in a 
representative section of a whole embryo at E18. Sense: 
autoradiogram obtained using specific sense probe for Cx43. 
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of clusters of Cx39-mRNA-positive cells surrounded by Cx39-mRNA-negative cells 
(Fig.5A). Between E17 and E18, the myotubes were better defined, with a large cytoplasm 
and central nucleus, and the level of Cx39 mRNA was high with hybridization grains being 
localized over the nucleus and cytoplasm (Fig.5B). Remarkably at E20, Cx39 expression 
decreased in several muscles, and progressively disappeared in more differentiated 
myotubes, identified by their extensive cytoplasm or peripheral nuclei. Between E21 and the 
first day of postnatal life, the majority of muscles showed a reduction of Cx39 labeling. An 
analysis of Cx39 expression was also performed in the gastrocnemius muscle at various 
postnatal days. At P1, a feature of Cx39 mRNA distribution was its presence over residual 
rows of closely apposed aligned cells or  
Fig.4 
Dark-field microautoradiograms showing Cx39 mRNA 
labeling in representative skeletal muscles. (A) 
Developmental stage E12. (B–F) Developmental stage E16. 
(G–H) Autoradiograms obtained by using specific sense 
probe. Scale bar 200 μm 
Diaphragm
 Hindlimb m.
 Hindlimb m.
Thoracic m.
Tongue
Vibrissae m.
Myotomes
A B
C D
E F
G H
Vibrissae m.
Sense Sense
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Fig.5 
Microautoradiograms showing Cx39 mRNA labeling in cresyl-violet-stained sections of 
developing hindlimb skeletal muscle at embryonic stages E15 and E18 (dotted rings Cx39 labeled 
cells with extensive cytoplasm in B and with little cytoplasm in A). C-D, identification of cells 
expressing Cx39 mRNA in developing skeletal muscles by combining in situ hybridization for 
Cx39 mRNA and immunohistochemistry for myogenin. The doublelabeling analysis at E15 and 
E16 revealed that all rCx39-mRNAlabeled cells (black grains) were also positive for myogenin 
(brown). Arrows indicate colocalization of Cx39 mRNA in myogenin positive nuclei. Arrowheads 
indicate myogeninpositive cells devoid of Cx39 mRNA labeling. Bar 20 μm 
E16
D
E15 E15
E18
A
B
C
Fig.6 
A–C In situ hybridization analysis of Cx39 expression in hematoxylin–eosin-stained sections of 
postnatal gastrocnemius muscle at various postnatal days (P1, P4, and P7). D Doublelabeling 
analysis (Cx39 + Pax7) at P1 showing that Cx39 mRNA does not co-localize with Pax7- positive 
nuclei, a marker for activated satellite cells. Arrows indicate Cx39 mRNA-labeled cells. Scale bar 
20 μm (A–C), 25 μm (D) 
P4P1
P7 P1
Cx39+Pax7
A B
C D
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individual cells (Fig.6A) and its absence in muscle regions containing more differentiated 
myotubes. At P4, Cx39 expression further decreased (Fig.6B) and disappeared within the 
first week of postnatal life (Fig.6C). 
 
Expression of Cx43 
The first signal of Cx43 mRNA expression was observed at E11 at the myotome level. 
At E15  the analysis of cresyl-violet-stained sections revealed the presence of clusters of 
Cx43-mRNA-positive cells surrounded by Cx43-mRNA-negative cells (Fig.7A). At E18 
Cx43 positive cells were located as individual cells only around cluster of myotubes (Fig.7 
C, E), suggesting a Cx43 expression in satellite cells. At P1, a feature of Cx43 mRNA 
Fig.7 
In situ hybridization analysis of Cx43 and Cx45 mRNA 
expression, during embryonic development. A and B 
development stage E15. C and D development stage E18. E and 
F Microautoradiograms showing Cx43 and Cx45 mRNA 
labeling in cresyl-violet-stained sections of developing hindlimb 
skeletal muscle at embryonic stages E18.
BA
C 
Cx43
Cx45x43
C  D
E F
Cx45
Cx45
Cx43 Cx45
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positive cell distribution was their presence over individual cells located around 4-5 
myofibers in transverse section and in aligned cells in longitudinal section The levels of 
Cx43 positive cells found at P1 progressively decrease and reach the adult levels at P23. 
 
Expression of Cx45 
The first signal of Cx45 mRNA expression was observed at E11 at the myotome level 
virtually involving all the cells. Between E11 and E17 Cx45 was expressed in a large 
number of cells and at E18 Cx45 positive cells were located only around the myotubes 
(Fig...7 B,D and F). Between P1 and P7 several Cx45 positive cells forming clusters were 
observed, with a progressive reduction already at P10. In the adult muscle Cx45 was found 
expressed in individual cells located along the myofibers, suggesting an expression in 
satellite cells. 
 
Cxs expression in normal and regenerating muscle of adult rat 
 
Cx (Cx30, Cx37, Cx39, Cx40, Cx43, and Cx45) mRNA expression was analyzed by 
the in situ hybridization method at different time points (6, 12, and 24h; 2, 3, 5, 7, 9, and 12 
days; 2, 3, and 4 wk) from gastrocnemius crush injury.  
Cx30 mRNA expression. 
Cx30 was not expressed either in the control uninjured or in the regenerating injured 
muscle (data not shown). 
Cx37 mRNA expression. 
In control, uninjured muscle, low levels of Cx37 mRNA were detected only in the 
endothelial cells of blood vessels (Fig.8A). Twenty-four hours following the crush injury, 
Cx37 expression was upregulated surrounding the area of lesion in the endothelial cells 
(Fig.8B). Between 24 and 72h from the crush injury, Cx37 mRNA-labeled cells increased 
and formed rows of cells migrating from the blood vessels to the area of lesion (Fig.8C). 
Three days after injury, Cx37 mRNA-expressing cells were found inside the area of lesion 
(Fig.8D), and, by 7–9 days after injury, they were distributed in the internal layer of circular 
cell clusters, some of which differentiated in blood vessels with endothelial cells expressing 
Cx37 (Fig.8, E and F). Twelve days after injury, Cx37 mRNA expression in the area of 
lesion was restricted to endothelial cells of newly generated blood vessels. In all of the time 
points examined, Cx37 was also expressed in the vessels of undamaged tissue.  
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Cx39 mRNA expression. 
In control, uninjured muscle, Cx39 mRNA was not detectable. Three days after crush 
injury, we could observe the appearance of Cx39 mRNA-labeled cells along the border 
between the area of lesion and the uninjured muscle fibers. Cx39 mRNA-labeled cells 
Day 1
Day 2
Day 9
Day 7
Day 3
control
A B
C
E
G
F
D
Day 12
V
V
V
Cx37
Fig.8 
Micro-autoradiograms showing connexin (Cx) 37 mRNA labeling in hematoxylin-eosin-stained 
sections of gastrocnemius muscle at different time points [control (A); day 1 (B); day 2 (C); day 3 
(D); day 9 (E); day 12 (F); day 7 (G)] from crush injury. Detailed information is given in 
RESULTS. In G is shown an overview of lesioned area. Arrows indicate Cx37 mRNA-labeled 
cells nuclei (black grains). V, vessel. Scale bar: 25 µm (A–F); 250 µm (G). 
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increased inside the area of lesion between 4 (Fig.9A) and 5 days after injury and were 
distributed as scattered cells, although small clusters of two and three cells were also 
observed. From 5 to 9 days after injury, Cx39 mRNA-labeled cells further increased and 
were mainly forming rows of aligned and closely apposed cell nuclei (Fig.9B). By 9 days 
from injury, in the regenerating area, Cx39 mRNA positive cells formed clusters with 
Day 9
Day 4
Day 9
Day 7
Day 9
Day 7
A B
C
E
G
F
D
Day 9
Cx39
Fig. 9. 
Micro-autoradiograms showing Cx39 mRNA labeling in hematoxylin-eosin-stained sections of 
gastrocnemius muscle at different time points [day 4 (A), day 7 (B and G), day 9 (C–F)] from crush 
injury. In G is shown an overview of lesioned area. Arrows indicate Cx39 mRNA-labeled cells nuclei 
(black grains). Arrowheads in F indicate cells nuclei poorly labeled with Cx39 mRNA compared with 
cells nuclei in C–E. Scale bar: 25µm (A–F); 250 µm (G). 
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heterogeneous morphology: 1) clusters in which cell nuclei with intense labeling were 
closely apposed to each other, probably corresponding to an early stage of cell aggregation 
before cell fusion (Fig.9C); 2) clusters in which cell nuclei were separated by an increasing 
eosinophilic sarcoplasm, representing a more advanced stage of myotube formation (Fig.9, 
D and E); 3) poorly labeled clusters in which a further increase in size of the eosinophilic 
sarcoplasm delineated the typical appearance of myotubes with centrally located nuclei 
(Fig.9F). Between 9 and 15 days, the Cx39 expression was still present but progressively 
decreased until its complete disappearance at 21 days from injury. Cx39 mRNA-labeled 
cells were always strictly localized inside the area of lesion and were never observed in the 
surrounding uninjured fibers or in the blood vessels. 
 
 
Cx40 mRNA expression 
In control, uninjured muscle, Cx40 was expressed at very low levels in the endothelial 
cells of blood vessels (Fig.10A). Twenty-four to forty-eight hours after injury, a strong 
expression of Cx40 mRNA appeared surrounding the area of lesion in the endothelial cells 
(Fig.10B). Three days after the injury, rows of Cx40 mRNA-labeled cells were migrating 
from the vessels to the area of lesion (Fig.10C). Between 4 and 5 days from injury, Cx40 
mRNA-labeled cells were inside the area of lesion, mainly distributed as scattered cells, 
although small clusters of two and three cells were also observed. Between 5 and 9 days 
from injury, the number of Cx40 mRNA-labeled cells in the area of lesion was further 
increased, mainly forming rows of closely apposed cell nuclei (Fig.10D) that could 
correspond to an early stage of cell aggregation before cell fusion. Nine days after injury, in 
the regenerating area, Cx40 mRNA-labeled cells formed clusters with heterogeneous 
morphology (Fig.10E) similar to those above described for Cx39. In the regenerating area, 
Cx40 was also expressed in clusters of cells probably committed to generate new vessels 
and in the endothelial cells of new blood vessels (Fig.10F). The spatial and temporal 
patterns of Cx40-expressing cells involved in new blood vessel formation were similar to 
that described for Cx37. The number of Cx40 mRNA-labeled cells progressively decreased 
between 15 and 21 days after injury. Four weeks after injury, Cx40 mRNA expression was 
restricted to endothelial cells.  
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Cx43 mRNA expression 
In control, uninjured muscle, Cx43 was weakly expressed in scattered cells along the 
basal lamina of muscle fibers (Fig.11A). An increase of Cx43 mRNA-labeled cells was 
already observed 3h following the crush injury in the uninjured zones of the muscle. The 
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Fig. 10 
Micro-autoradiograms showing Cx40 mRNA labeling in hematoxylin-eosin-stained sections 
of gastrocnemius muscle at different time points [control (A), day 2 (B), day 3 (C), day 7 (D 
and G), day 9 (E), day 12 (F)] from crush injury. In G is shown an overview of lesioned area. 
Arrows indicate Cx40 mRNA-labeled cells nuclei (black grains). Cluster of cells with different 
morphology are shown in E, where circled area indicates cell nuclei poorly labeled with Cx40 
mRNA with increasing eosinophilic sarcoplasm, representing a more advanced stage of 
myotube formation. Scale bar: 25 µm (A–F);250 µm (G). 
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number of Cx43 mRNA-labeled cells progressively increased between 6 and 12h from 
injury, involving region distant from the area of lesion (Fig.11B). Between 24 and 48h from 
injury, Cx43 mRNA-labeled cells accumulated in the region surrounding the lesioned area 
Fig.11 
Micro-autoradiograms showing Cx43 mRNA labeling in hematoxylin-eosin-stained sections of 
gastrocnemius muscle at different time points [control (A), 12 h (B), day 2 (C), day 3 (D), day 7 (E and H), 
day 9 (F and G)] from crush injury. In H is shown an overview of lesioned area. Arrows indicate Cx43 
mRNA-labeled cells nuclei (black grains). In F, circled area indicates cell nuclei Cx43 mRNA negative 
with increasing eosinophilic sarcoplasm, representing a more advanced stage of myotube formation. In G, 
Cx43 mRNA-labeled cells (arrows), probably corresponding to new satellite cells, were located along the 
basal lamina of new myofibers. Scale bar: 25 µm (A–F); 50 µm (G); 250 µm (H). 
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(Fig.11C). Between 3 and 4 days from injury, a large number of Cx43 mRNA-labeled cells 
were located inside the area of lesion (Fig.11D). Although in large number, the Cx43 
mRNA-labeled cells were never forming rows of closely apposed cell nuclei, as we could 
observe for Cx39 or Cx40 mRNA-labeled cells. However, among the apparent irregular 
distribution of Cx43-labeled cells, there was a specific localization of Cx43-labeled cells 
along the growing border of new myotubes (Fig.11E). This type of Cx43 mRNA-labeled cell 
distribution increased between 6 and 9 days and was still present during the subsequent days 
until there was a complete regeneration of the injured area that took place 4 wk after injury. 
Interestingly, in the regenerated area, single Cx43 mRNA-labeled cells, probably 
corresponding to new satellite cells, were located along the basal lamina of new myofibers 
(Fig.11, F and G). We never observed Cx43 labeling in the endothelial cells, including the 
newly formed one in the regenerated area. 
 
Cx45 mRNA expression 
In control, uninjured muscle, the Cx45 was weakly expressed in scattered cells along 
the basal lamina of muscle fibers (data not shown). An upregulation of Cx45 mRNA was 
already observed at 6h from injury (Fig.12A) in individual cells along the uninjured fibers 
surrounding the lesioned area (Araya et al. 2005). Between 12 and 48h from injury, Cx45 
mRNA-labeled cells increased and formed chains of cells migrating inside the area of lesion 
(Fig.12B). Between 3 and 4 days from injury, Cx45 mRNA-labeled cells accumulated inside 
the area of lesion (Fig.12C). Between 4 and 9 days from injury, the number of Cx45 mRNA-
labeled cells further increased in the area of lesion. Similar to Cx43, Cx45 mRNA-labeled 
cells were never forming clusters of aligned and closely apposed cell nuclei. However, 
among the apparent irregular distribution of Cx45-labeled cells, there was specific 
localization along the growing border of new myotubes (Fig.12D). This type of Cx45 
mRNA-labeled cells was still present during the subsequent days until there was a complete 
regeneration of injured area. In contrast to Cx43, we did not observe single Cx45 mRNA-
labeled cells along the basal lamina of new myofibers. Although in control, uninjured 
muscle and also surrounding the area of lesion, Cx45 was never observed in the blood 
vessels (Fig.12F), in the regenerating area, we could observe Cx45-labeled cells in the 
external layer of cell clusters probably committed to generate new vessels and both in the 
vascular smooth cells and in endothelial cells of newly formed blood vessels (Fig.12E), as 
also reported by Araya et al. (Araya et al. 2005).  
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Fig.12 
Micro-autoradiograms showing Cx45 mRNA labeling in hematoxylin-eosin-stained sections of 
gastrocnemius muscle at different time points [6 h (A), day 2 (B), day 3 (C), day 7 (D and G), day 12 
(E), control (F)] from crush injury. In G is shown an overview of lesioned area. Arrows indicate Cx45 
mRNA-labeled cells nuclei (black grains). Arrowheads indicate endothelial cells Cx45 mRNA 
negative. Scale bar: 25 µm (A–F); 250 µm (G). 
Day 26h
Day 3
Day 12
Day7
A B
C
E F
D
control
V
V
V
Cx45
Day 7
G
 
39 
Dott.ssa M. Frinchi 
Morphological distribution of cells expressing Cx39, Cx40, Cx43, and Cx45 in 
the area of lesion. 
 
In the regenerating area along the growing border of new myotubes, Cx43 or Cx45 
mRNA-labeled cells seemed to form, as shown in figure 13‐C, -C1, -D, and -D1, a front of cells 
that progressively generate chains of aligned and closely apposed cell nuclei. These aligned 
and fusing cell nuclei were labeled for Cx39 or Cx40 mRNAs (Fig.13A, A1, B, and B1).  
Fig. 13 
Micro-autoradiograms showing Cx39 (A and A1), Cx40 (B and B1), Cx43 (C and C1), and Cx45 (D and D1) 
mRNA labeling in hematoxylin-eosin-stained sections of gastrocnemius muscle at 7 days from crush injury. 
A–D: low magnification showing differentiating new myotubes (arrows) in the regenerating area. A1–D1: 
high magnification of the area indicated in the square of A–D, corresponding to growing region of selected 
myotube. Arrows in A–D indicate the growing new myotube. Arrows in A1–D1 indicate Cx mRNA-labeled 
cell nuclei (black grains). Scale bar: 100 µm (A–D); 25 µm (A1–D1). 
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Identification of Cx‐expressing cells. 
 
To identify the myogenic cell types involved in Cx mRNA expression, a double-
labeling was performed by combining in situ hybridization and immunohistochemistry. A 
combination of specific markers was used to identify early activated satellite cells or 
differentiating myogenic cells  until  their fusion  in myotubes:  M-cadherin  , as marker for 
quiescent, active, and replicative satellite cells (Irintchev et al. 1994), and myogenin, as 
marker for myogenic cells differentiating in myoblasts and myocytes forming myotubes 
(Creuzet et al. 1998). The double-labeling analysis was performed in injured gastrocnemius 
muscles at three critical time point (1, 3, and 9 days from injury). Cx37 mRNA was never 
Fig.14 
Cx37 (A), Cx40 (D), and Cx45 (G) colocalization with von Willebrand factor (vWF; B, 
E, and H) in gastrocnemius muscle at 9 days from crush injury. C, F, and I: overlay 
showing Cx37, Cx40, and Cx45 (red), respectively, colocalizing with vWF (green). 
Scale bar: 50 µm. 
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colocalized in M-cadherin or myogenin-positive cells (data not shown), in accordance with 
its expression restricted to endothelial cells of both preexistent and newly formed blood 
vessels, as identified using anti-vWF antibodies specific for endothelial cells (Fig.14, A–C). 
Cx39 mRNA was always colocalized in myogenin-positive cells mainly forming clusters of 
aligned and closely apposed cell nuclei or in myogenin-positive cells forming cluster with 
heterogeneous morphology corresponding to different advanced stages of myotube 
formation (Fig.15A). Virtually all Cx39-labeled cells were myogenin-positive cells. Cx40 
Fig 15 
Micro-autoradiograms showing colocalization of Cx43 (C) and Cx45 (E) mRNAs labeling in cadherin 
positive cells and Cx39 (A), Cx40 (B), Cx43 (D), and Cx45 (F) mRNAs in myogenin-positive cells of 
gastrocnemius muscle, respectively, at 1 and 9 days from crush injury. G: colocalization of Cx43 mRNA 
labeling (blackgrains) in CD11b-positive cells (brown). Arrows indicate colocalization of Cx mRNA 
labeling (black grains) in cadherin (brown; C and E) or myogenin (brown; A, B, D, and F) or CD11b-positive 
cells (brown; G). Arrowheads (D and F) indicate cluster of cells with large sarcoplasm and with myogenin-
positive nuclei devoid of specific Cx RNA labeling. Scale bar: 25 µm. 
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mRNA inside the area of lesion was also colocalized in myogenin-positive cells forming 
clusters with profiles similar to those described for Cx39 (Fig.15B). However, in contrast to 
Cx39, the Cx40 was also found expressed in endothelial cells of both preexistent and newly 
formed blood vessels (Fig.14, D–F). In control tissue and 1 day after injury, Cx43 mRNA 
was colocalized in M-cadherin-positive cells (Fig.15C), but not all Cx43 mRNA-labeled 
cells were positive for M-cadherin. Three and nine days after injury, Cx43 mRNA was 
colocalized in individual myogenin-positive cells, but again not all Cx43-labeled cells were 
positive for myogenin (Fig.15D). Using anti-CD11b antibodies to identify 
macrophages/monocytes, we could find that Cx43 mRNA is expressed in CD11b-positive 
cells (Fig.15G). However, Cx43 mRNA was not expressed in aligned and closely apposed 
myogenin-positive cell nuclei or in cluster of cells with large cytoplasm, representing more 
advanced stages of myotube formation (Fig.15D). One day after injury, Cx45 mRNA was 
expressed in M-cadherin-positive cells (Fig.15E), but not all Cx45 mRNA-labeled cells were 
positive for M-cadherin. Inside the area of lesion, both 3 and 9 days after injury, Cx45 
mRNA was colocalized in individual myogenin-positive cells, but not all Cx45-labeled cells 
were myogenin positive (Fig.15F) (Araya et al. 2005). Using anti-vWF antibodies, Cx45 
was also found coexpressed in new blood vessels (Fig.14, G–I). However, Cx45 mRNA was 
not expressed in aligned and closely apposed miogenin-positive cell nuclei or in cells with 
large cytoplasm, representing more advanced stages of myotube formation (Fig.15F).  
 
Colocalization of Cx39 and Cx40. 
Because from 5 to 9 days after muscle injury both Cx39 and Cx40 mRNA-labeled 
cells were mainly forming clusters of aligned and closely apposed cell nuclei (Figs 9B and 
10D) that could correspond to an early stage of cell aggregation before cell fusion, we argue 
the possibility that Cx39 and Cx40 were coexpressed in the pre or fusing cells. To this end, 
we performed, at 7 days from lesion, a double immunolabeling using specific antibodies for 
Cx39 and Cx40. Both Cxs were detected as puncta localized in clusters of cells in the area of 
lesion. All cluster of cells expressing Cx40 were also Cx39 positive, whereas several 
clusters of cells were only Cx39 positive (Fig.16D). The developing skeletal muscle at 
embryonic day 15 was used as internal positive control (Fig.16, G-I).  
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Cx expression in BrdU-positive cells. 
This study was performed to verify the possibility that Cx40 and Cx39 mRNA could 
be expressed in proliferating myogenic precursor cells. To this end, we labeled proliferating 
cells by injection of BrdU at three time points (3, 5, and 7 days) from muscle injury. Cx39 
mRNA was not expressed in BrdU-positive cells at all time points studied, suggesting that it 
can be expressed only in differentiating myogenic cells (Fig.17B). Three days after lesion, 
Cx40 mRNA was expressed in 16 ± 3.4% of BrdU-positive cells mainly located around the 
blood vessels (Fig.17C). By contrast, in the same experimental condition, Cx37 and Cx43 
mRNAs were expressed, respectively, in about 18 ± 4.3% and 80 ± 8.9% of BrdU-positive 
cells (17A,C). The other two time points examined showed a comparable trend.  
E15 
Fig.16 
Cx39 (A, D, and G) and Cx40 (B, E, and H) immunolabeling in 
gastrocnemius muscle at 7 days from crush injury. Note the 
immunostaining as typical puncta (A and B, D and E, G and H) 
mainly localized in clusters of aligned and closely apposed cells. 
C: overlay showing Cx40 (red) colocalizing with Cx39 (green). 
F: overlay showing absence of Cx40 (red) in Cx39 (green) 
positive cells. G–I: show, as internal control, immunostaining 
for Cx40 and Cx39 in developing intervertebral skeletal muscle 
at embryonic day 15 (E15). Scale bar: 50 µm. 
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AIM II 
 
Low‐intensity endurance exercise effects on damaged skeletal muscles in 
mouse and rat 
 
Low-intensity endurance exercise 
Exercise training protocol (Tab I) on the rotarod apparatus. 
Fig.17 
Micro-autoradiograms showing colocalization of Cx37 (A), Cx39 (B), Cx40 (C), and Cx43 
(D) mRNA labeling in bromodeoxyuridine (BrdU)-positive cells of gastrocnemius muscle at 
representative time points from crush injury. Note in B the absence of colocalization of Cx39 
mRNA labeling (black grains) in Brdu positive cells (gray), and in A, C, and D the 
colocalization, respectively, of Cx37, Cx40, and Cx43 mRNA labeling in BrdU-positive 
cells. Arrows indicate cells with Cx mRNA labeling (black grains) and BrdUpositive nuclei 
(gray). Scale bar: 25 µm. 
Cx37+BrdU Cx39+BrdU
Cx40+BrdU Cx43+BrdU
A
C D
B
Day 2 Day 5
Day 2 Day 2
Week Session time 
(min) 
Rotations/min 
(RPM) 
Length 
(m) 
Speed 
(m/min) 
1 30 20 120 4 
2 45 20 180 4 
3 60 20 240 4 
4 60 24 288 4.8 
Table I. Training protocol on the rotarod apparatus. 
 
45 
Dott.ssa M. Frinchi 
Functional recovery of skeletal muscle in mdx mice  
 
Body weight and exercise 
As shown in Figure 18, at the beginning of exercise training protocol (Tab I) on the 
rotarod apparatus, body weight in MDX-EX (26.2  2.2g) and MDX-SD (24.8  1.9g) mice 
was significantly lower compared to WT-EX (27.9  1.8g; p<0.05) and WT-SD (28.0  
2.0g; p<0.001) mice. After 2 weeks of training, body weight was still significantly lower in 
MDX-SD (26.8  2.0g) mice as compared to WT-SD (28.8  2.3g, p<0.05) mice. After 3 and 
4 weeks of training no significant differences were found between groups; however,  in 
MDX-EX mice body weight tended to be lower than in MDX-SD mice. 
 
Fatigue 
The time course of fatigue resistance was analyzed for each group of mice and in all 
groups a reduced not significant grip strength fatigue was observed (Fig.19). However, there 
Fig.18 
Body weight changes in sedentary and exercised mdx and wild type mice during 
training period. Data are expressed as means. MDX-SD: sedentary mdx mice; 
MDX-EX: exercised mdx mice; WT-SD: sedentary wild type mice; WT-EX: 
exercised wild type mice. 
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was a non significant trend of fatigue resistance improvement in MDX-EX mice as 
compared to MDX-SD mice.  
 
Forelimb strength normalized for weight  
Forelimb strength normalized for body weight (FSW, gram strength per gram of body 
weight) did not show significant difference between all groups at any time point of the 
training protocol. The time course of FSW was also analysed inside each group of mice and 
were found significant variations between week 1 and 3, and reported as follows: in MDX-
EX, FSW was 2.40  0.61g/g at week 1 and 1.88  0.34g/g at week 3 (p<0.05); in WT-EX, 
FSW was 2.29  0.5 g/g at week 1 and 1.76  0.57g/g at week 3 (p<0.0001); in WT-SD, 
FSW was 2.15  0.46g/g at week 1 and 1.64  0.28g/g at week 3 (p<0.05). In MDX-SD, 
FSW did not change at any time point.  
 
 
Fig.19 
Grip strength fatigue in sedentary and exercised mdx and wild type mice during 
training period. Data are expressed as means. MDX-SD: sedentary mdx mice; 
MDX-EX: exercised mdx mice; WT-SD: sedentary wild type mice; WT-EX: 
exercised wild type mice. 
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Recovery of damaged skeletal muscle in mdx mice  
 
Histomorphological analysis 
Histological analyses on muscle tissue sections were used to assess the effect of low-
intensity endurance exercise on muscle pathology progression of mdx mice. The Figure 2 
shows representative sections for each group, along with the main differences found in the 
muscle histology as a consequence of exercise. No evident difference was found in muscle 
of sedentary and exercised wild type mice and was apparently absent both necrosis and 
regenerating processes in exercised mice (Fig.20, A, B), suggesting that low-intensity 
endurance exercise did not cause damage to myofibres. Skeletal muscle of non-exercised 
(sedentary) mdx mice showed in all time points examined, in both gastrocnemius and 
quadriceps muscles, a typical histopathological signs with necrosis foci, fibrous connective 
tissue and areas with active processes of degeneration/regeneration of damaged  myofibres 
(Fig.20C). By contrast, histomorphological analysis of exercised mdx mice showed a 
progressive almost complete disappearance of areas with inflammatory necrotic myofibres 
and a parallel increase of regenerating myofibres in the gastrocnemius as well as in the 
quadriceps muscle (Fig.20D, F). Histological evidence of increased areas showing 
regenerated myofibres, distinguished for the central location of aligned nuclei, was recorded 
already in muscle of mice exercised for 15 days (Fig.20D). The muscle morphology in 
exercised mdx mice for 30 days showed several regenerated myofibres and all necrotic foci 
under regenerating process (Fig.20E). In mdx mice exercised for 45 days the analysis 
showed very few regenerating myofibers and a large number of regenerated myofibres 
(Fig.20F), suggesting a potential complete recovery of damaged muscle. This progressive 
accumulation of newly regenerated myofibres with nuclei in central location may find 
explanation with the current observation that central myonuclei may last for about 50–100 
days and thereafter move to a peripheral subsarcolemmal position (McGeachie et al. 1993).  
 
48 
Dott.ssa M. Frinchi 
 
 
Cx39 protein levels as marker of regenerative process in injured muscle of C57BL6 
mice 
 
In the adult skeletal muscle, various kinds of trauma promote proliferation of satellite 
cells that differentiate into myoblasts to form new myofibers, or to repair the damaged one. 
In the rat gastrocnemius following injury the Cx39 is upregulated only during the 
regeneration process and is involved in myogenic cells aggregation and fusion to form new 
myotubes (Belluardo et al. 2005; Trovato-Salinaro et al. 2009). Therefore the detection of 
Cx39 protein can be used as marker associated with active regeneration processes of 
damaged muscle. Here, we performed a time course of muscle regeneration in C57BL/6 
Fig.20 
Representative skeletal muscle sections stained with haematoxylin-eosin from wild type and mdx mice. No 
apparent morphological difference there exist in sedentary and exercised wild type mice (A-B). A 
consistent myofibre necrosis is present in sedentary mdx mice (C), whereas areas of progressive subsequent 
regeneration are present in exercised mdx mice with increased new myofibres (D-F) with central nuclei that 
are a reliable indicator of previously necrotic/regenerated tissue. For detailed explanation see results 
section. WT-SD, sedentary wild type; WT-EX, exercised wild type; MDX-SD, sedentary mdx; MDX-EX, 
exercised mdx. Arrows indicate active processes of degeneration with many disorganized nuclei, probably 
inflammatory cells and cells involved in regenerating process. Arrowed indicate regenerating and 
regenerated myofibres with aligned central nuclei. Scale bar 50µm
WT-s WT-ex 30 days
MDX-s MDX-ex 15 days
MDX-ex 30 days MDX-ex 45 days
A B
C D
E F
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mice following mechanical injury in order to corroborate the critical expression of Cx39 in 
regenerating muscle. In Figure 21B representative gastrocnemius muscle sections from 
control and following 8 days from injury are shown. Concerning Cx39 protein levels 
(Fig.21), in control uninjured muscle Cx39 was undetectable, as previously reported for 
Cx39 mRNA. (Trovato-Salinaro et al. 2009). In the injured muscle fibres, Cx39 protein level 
was undetectable until three days following crush injury, whereas it was found increased 
after 8 days and showed a strong reduction 11 days after injury (Fig.21). Cx39 disappeared 
21 days following injury (Fig.21), when the injured area was completely repaired. Overall, 
this model confirm that, during muscle regeneration following crush injury, there can be a 
transient activation of Cx39 in the area of lesion testifying active regeneration process 
(Belluardo et al. 2005). 
Fig.21 
Western blotting analysis of Cx39 protein levels. (A) Time-course (3,8,11 and 21 days 
from injury) of Cx39 protein levels in the injured gastrocnemious of C57Bl/6 mice as 
compared to control muscle (uninjured). E15: internal positive control of Cx39 in 
developing skeletal muscle of E15 embryonic mouse.(B) Representative 
gastrocnemious muscle sections from control and following 8 days from injury. Scale 
bar: 50µm 
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Evaluation of muscle regenerative process in mdx mice by measuring Cx39 proteins 
levels  
 
In the present work, in order to follow the recovery of damaged muscle in mdx mice, 
we used the detection of Cx39 protein as marker associated with active regeneration 
processes of damaged muscle. Therefore, in addition to morphological point of view, the 
levels of regeneration process in the gastrocnemius or quadriceps of exercised mdx mice 
were also evaluated by examining the Cx39 protein levels. Cx39 protein, as expected, was 
not detected in muscles of wild type C57BL/10 mice, both in sedentary and exercised mice 
(Fig.22). In sedentary mdx mice Cx39 protein levels, both in gastrocnemius and quadriceps 
muscles, were found markedly increased because of active degeneration/regenerating 
processes (Fig.22). In exercised mdx mice (15, 30 and 45 days), Cx39 protein levels dropped 
progressively, as compared to sedentary mdx mice, to very low levels (Fig.22). These data, 
according to those of morphological analysis, indicated a strong reduction of regeneration 
processes in muscle of mdx mice exercised for 45 days and suggested almost a full recovery 
of damaged muscle. 
Fig.22 
Western blotting analysis of Cx39 protein levels. (A-B) Cx39 protein levels in gastrocnemius and 
quadriceps skeletal muscles of wild type mice, sedentary (wt-sd) or exercised (wt-ex), and mdx 
mice, sedentary (mdx-sd) or exercised (mdx-ex) for 15, 30 and 45 days. E15: internal positive 
control of Cx39 in developing skeletal muscle of E15 embryonic mouse. 
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DISCUSSION 
 
 
 
Role of Cxs expressed in regenerating muscle. 
 
Among the Cxs examined, only the Cx39, Cx43 and Cx45 were found expressed 
during embryonic life and progressively reduced during early postnatal life until to become 
dramatically expressed at very low levels like Cx43 and Cx45 or to be undetectable like 
Cx39 in the adult muscle. The other Cxs, although expressed at low levels, were found 
localized in the endothelial cells (Cx37 and Cx40) according to previous data (Araya et al. 
2005; Gorbe et al. 2005). Although gap-junctional communication is absent in adult skeletal 
muscle, the presence of gap junctions during skeletal muscle development has been 
previously documented by functional and ultrastructural studies (Schmalbruch 1982; 
Constantin and Cronier 2000; Rash and Staehelin 1974; Kalderon et al. 1977; Duxson et al. 
1989). Multinucleated muscle cells are formed by the fusion of mononucleated myoblasts 
that are aligned, closely apposed, and interconnected by gap junctions during the pre-fusion 
phase (Schmalbruch 1982; Constantin and Cronier 2000; Rash and Staehelin 1974; Kalderon 
et al. 1977; Constantin et al. 1997; Balogh et al. 1993; Araya et al. 2003; Mege et al. 1994; 
Proulx et al. 1997; Duxson and Usson 1989). Moreover, the presence of gap junctions 
between myotubes in differentiating skeletal muscles has been reported at the ultrastructural 
level (Ling et al. 1992). Data with respect to the molecular identity of the connexins forming 
inter-myoblast gap junctions are available. Cx43 and Cx40 have been previously described 
in myoblasts of differentiating skeletal muscles (Dahl et al. 1995), and evidence in favor of a 
functional role of Cx43 in the differentiation and fusion of myoblasts (Balogh et al. 1993; 
Mege et al. 1994; Proulx et al. 1997; Araya et al. 2003) has been reported in culture 
systems. Indeed, following the chemical block of gap junctions or after deletion of the Cx43 
gene, cultured myoblasts do not fuse with each other and do not express specific genes for 
cellular differentiation, such as myogenin (Schmalbruch 1982; Constantin and Cronier 2000; 
Rash and Staehelin 1974; Kalderon et al. 1977; Duxson and Usson 1989; Constantin et al. 
1997; Balogh et al. 1993; Araya et al. 2003; Mege et al. 1994; Proulx et al. 1997). The Cx39 
is expressed in aligned and closely apposed myogenin-positive myoblasts and in early 
myotubes and might participate in inter-myoblast and probably inter-myotube 
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communication in this critical phase of differentiation. The absence of Cx39 in activated 
satellite cells of early postnatal muscles and its disappearance within the first week of 
postnatal life suggests that this connexin is not involved in the process of postnatal growth 
of the muscle mass. Indeed, the postnatal growth of myofibers is dependent on the 
apposition and fusion of single activated satellite cells to existing myofibers, a process that 
takes place for several weeks after birth (Moss and Leblond 1971). Recently, using Cx39 
knockout mice, it has been showed (von Maltzahn  et al, in press) that Cx39 is not 
indispensable for myoblast fusion and therefore for myofibers formation probably because it 
is compensate by other Cxs, such as Cx43. 
The present study provided a comparative analysis of spatial and temporal mRNA 
expression of five Cxs in the regenerating skeletal muscle after crush injury. After muscle 
crush injury, the mRNAs of Cxs examined were upregulated in regenerating muscle with 
distinct spatial and temporal patterns involving, with exclusion of Cx37, myogenic cells. 
The endothelial localization and spatio-temporal distribution of Cx37 mRNA 
expression clearly revealed an involvement of Cx37 in the angiogenesis of regenerating 
muscle, although disruption of Cx37 did not result in obvious defects in vasculogenesis or 
vascular development (Simon and McWhorter 2003), probably because it could be 
compensated by other Cxs, such as Cx40 (Simon and McWhorter 2002). BrdU incorporation 
in Cx37 mRNA-labeled cells located in the endothelium of blood vessels, as shown both by 
histological observation and indirectly by Cx37/vWF colocalization, furthermore, could 
indicate the source of Cx37-expressing precursor cells involved in the angiogenesis of 
regenerating muscle.  
The expression of Cx39 mRNA in single myogenin-positive cells, in aligned and 
closely apposed cells, and in newly formed myotubes suggests that Cx39 may be involved in 
intercellular communication during the process of cell aggregation, coordination, and fusion 
to form new myotubes, according to previous data (Belluardo et al. 2005; von Maltzahn  et 
al. 2004). The spatial pattern of Cx39 mRNA expression shows a localization of Cx39 
mRNA restricted to the injured area where the formation of myotubes and myofibers takes 
place (Charge and Rudnicki 2004). The temporal pattern of Cx39 mRNA expression in 
injured muscle is correlated with the appearance of myogenin-positive cells in the area of 
lesion (3 days after injury) and with the peak of formation of new myotubes (7–9 days after 
injury). 
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In the present work, following muscle injury, was evidenced that Cx40 mRNA 
expression is upregulated in endothelial cells, as identified by vWF marker, and 
subsequently, within 3 days from injury, these Cx40 mRNA-expressing cells were migrated 
to the area of lesion where they followed alignment in closely apposed cells coexpressing 
Cx39 mRNA fuse in myotube. However, the observation that the majority of cell clusters 
expressing Cx39 mRNA were Cx40 mRNA negative opens the question about the possible 
existence in the skeletal muscle of two distinct myogenic precursor cells both committed to 
form new myotubes. In fact, currently it is believed that Cx39 mRNA is expressed in 
differentiating and fusing myoblasts generated by myogenic precursor cells or satellite cells 
expressing Cx43 mRNA and located between the basal lamina and the sarcolemma of their 
associated muscle fibers (Araya et al. 2005; Belluardo et al. 2005). Here we could show that 
Cx40 mRNA-expressing precursor cells located in the endothelium of blood vessels, as 
shown both by histological observation and indirectly by Cx37/vWF colocalization, may 
generate myoblasts fusing each other to form myotubes and, as showed by double-labeling 
immunohistochemistry, coexpressing Cx39. Additionally, myoblast cell line C2C12 cells do 
not express Cx40, although they express Cx43 and Cx39 (von Maltzahn  et al. 2006). This is 
the first report showing, in regenerating muscle, that blood vessels might be a source of 
Cx40-expressing myogenic precursor cells committed to become myoblasts fusing in 
myotube. The existence of myogenic cells related to the endothelial cell lineage in human 
skeletal muscle or in mouse embryo muscle has been reported by Zheng et al. (2007) and by 
Le Grand et al. (2004), respectively. Additionally, Cx40 mRNA-positive cells could also be 
related to pericytes associated with microvasculature walls that efficiently contribute to 
myogenic regeneration (Dellavalle et al. 2007), or to mesoangioblast cells, an adult vessel-
derived stem cell that possess high myogenic potential (Sampaolesi et al. 2006). 
Furthermore, myogenic precursor cells expressing Cx40 may also derive from the blood. 
However, specific markers and studies are needed to define the profile of the precursor 
endothelial Cx40 positive cells and their relationship with myogenic precursor cells 
generating Cx39-expressing cells. The parallel expression of Cx40 in endothelial cells of 
new blood vessels further suggests an expression in precursor cell involvement in blood 
vessel generation, although disruption of Cx40 did not result in obvious defects in 
vasculogenesis or vascular development (Simon and McWhorter 2003). However, Cx37 and 
Cx40 could be co-expressed in endothelial precursor cells, and could overlap functionally in 
generating vessels, as revealed by severe vascular abnormalities after elimination of both 
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Cxs (Simon and McWhorter 2002). This possibility implicates a Cx40-expressing precursor 
cell population distinct from that one involved in the new myotube formation. 
A few hours after injury, we observed an upregulation of Cx43 mRNA and an increase 
of Cx43 mRNA-labeled cells in a large area around the lesion, but only a minor percentage 
of them were myogenic precursor cells, as shown by colocalization with M-cadherin marker. 
This result is in agreement with the present data showing that Cx43 mRNA is expressed in 
CD11b-positive cells, a marker for macrophages/monocytes, and with previous observations 
that, in regenerating muscle, both monocytes and macrophages also express Cx43 (Araya et 
al. 2005; Gorbe et al. 2005). The expression of Cx43 mRNA in M-cadherin-positive cells 
suggests a role in proliferating and differentiating satellite cells (Gorbe et al. 2005). Within 
3 days, a large number of Cx43 mRNA-labeled cells accumulated inside the area of lesion, 
and after 4–5 days the Cx43 mRNA-labeled and myogenin-positive cells appear to be 
organized in clusters or closely apposed to myoblasts forming new myotubes. Cx43 mRNA 
was never expressed in aligned, closely apposed myogenin-positive cells and in newly 
formed myotubes, suggesting that its functional role is played in stages preceding the 
myotube formation. A role for Cx43 in myoblast proliferation and syncytial fusion in 
regenerating skeletal muscle, or in muscle primary cultures has been recently reported 
(Araya et al. 2005; Gorbe et al. 2005). Thus Cx43-positive cells can proliferate inside the 
area of lesion, generating daughter cells expressing Cx39 and are committed to differentiate 
in myoblasts fusing in myotubes. This possibility is also supported by the observation that 
cells expressing Cx39 mRNA appear 3 days after the injury inside the area of lesion. 
Alternatively, cells expressing Cx39 may directly derivate from Cx43-positive cells after 
downregulation of Cx43 gene (Gorbe et al. 2005; von Maltzahn  et al. 2004; von Maltzahn  
et al. 2006). This hypothesis correlates with the lack of BrdU incorporation in Cx39 mRNA-
positive cells. In the regenerating area, single Cx43 mRNA-positive cells, probably 
corresponding to new satellite cells, were also observed along the basal lamina of newly 
myotubes or myofibers identified by the central position and high density of nuclei. 
It is well known that satellite cells in injured muscle proliferate and migrate inside the 
area of lesion, where they further proliferate and generate myogenic precursor cells (self-
renewed satellite cells) or myoblasts committed to generate by fusion the multinucleated 
myotubes (Charge and Rudnicki 2004; Zhao and Hoffman 2004). Similar to Cx43, a few 
hours after injury, a population of Cx45 mRNA-labeled and M-cadherin-positive cells was 
observed in a large area around the lesion. The expression of Cx45 mRNA in M-cadherin 
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cells suggests a role for this Cx in proliferating and differentiating satellite cells. Within 4–5 
days after injury, the Cx45 mRNA-labeled and myogenin-positive cells appear as single 
cells or organized in clusters or closely apposed to myoblasts forming new myotubes. Cx45 
mRNA was never found expressed in aligned, closely apposed, myogenin-positive cells and 
in newly formed myotubes, suggesting that its functional role starts in stages preceding the 
myotube formation. Although the pattern of Cx45 and Cx43 mRNA expression during 
muscle regeneration appears to be similar, there are observations supporting their expression 
in distinct myogenic precursor cell population. For example, in contrast to Cx43 mRNA-
labeled cells, we could not observe single Cx45 mRNA-positive cells along the basal lamina 
of newly formed myofibers. Additionally, myoblast cell line C2C12 cells do not express 
Cx45, although they express Cx43 and Cx39 (von Maltzahn  et al. 2006). However, specific 
investigations are needed to establish if Cx45- and Cx43-labeled cells are distinct myogenic 
precursor cell population. On the other hand, inside the injured area, Cx45 mRNA was also 
expressed in M-cadherin or myogenin-negative cells that probably are involved in 
angiogenesis, as also suggested by expression of Cx45 in the endothelial cells of newly 
formed blood vessels. This observation is supported by the finding that Cx45-deficient 
embryos exhibit defects in remodeling and organization of blood vessels after proper 
initiation of angiogenesis, and fail to form a smooth muscle layer surrounding the major 
arteries (Kruger et al. 2000). Taken together, these data confirm that also Cx45, similarly to 
Cx37 and Cx40, is involved in blood vessel generation (Kruger et al. 2000) and implicate a 
precursor cell population expressing Cx45 distinct from that one co-expressing Cx45 and 
myogenin, potentially involved in muscle regeneration, as also reported by Araya et al. 
(Araya et al. 2005). 
On the basis of results of the present and related previous studies, it appears that the 
distinct pattern of Cx40, Cx43, and Cx45 mRNA expression found during muscle 
regeneration could correlate with different populations of myogenic precursor cells that have 
been described to reside in the adult skeletal muscle (Bischoff 1986; Goldring et al. 2002; 
Hawke and Garry 2001; Schmalbruch and Lewis 2000; Seale and Rudnicki 2000; Zammit 
and Beauchamp 2001). By contrast, the Cx39 expression seems to be essential during 
myoblasts fusion, independently of precursor cell-type-generating myoblasts. As integrate 
information of the present data, we propose a model of Cx expression during the skeletal 
muscle regeneration process leading to new myofiber formation or repair of damaged ones 
(Fig.23). Cx40 mRNA-expressing cells seem to be generated by activated, proliferating 
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precursor cells localized in the blood vessels, and, subsequently, these Cx40 mRNA-
expressing cells migrate to the area of lesion, where, following differentiation in myoblasts 
and alignment in closely apposed cells, coexpressing Cx39 may generate new myotubes. 
Cx43 mRNA-expressing cells probably generate by activated proliferating satellite cells and, 
after migration in the area of lesion, may differentiate in myoblasts that following alignment 
in closely apposed cells expressing Cx39 mRNA fuse to form new myotubes (Araya et al. 
2005; Belluardo et al. 2005; von Maltzahn  et al. 2004; von Maltzahn  et al. 2006). The 
potential role of Cx45-expressing myogenic cells in the formation of new myotubes seems 
to be less clear. Potentially, myogenic cells expressing Cx45 mRNA could represent a 
distinct precursor cells, a subset of satellite cells, that generate myoblasts committed to 
repair the injured myofibers and/or to add myonuclei to growing new myofibers. 
Overall, in this model we suggest that, during muscle regeneration following crush 
injury, there can be activated two distinct myogenic precursor cell populations, expressing 
Cx40 and Cx43, committed to generate new myotubes and, therefore, new myofibers. For 
both of these myogenic precursor cell populations, the step of myoblast fusion to form new 
myotubes is characterized by the expression of Cx39. Recently, a functional study during the 
Fig.23 
Schematic representation of skeletal muscle regeneration following a crush injury, showing the potential 
role of cell expressing Cx39, Cx40, Cx43, and Cx45 during satellite cell activation, proliferation, their 
differentiation in myoblasts and fusion to form new myotube. 
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regeneration process of skeletal muscle in Cx39 deficient mice evidenced an accelerated 
onset of MyoD and myogenin expression, suggesting an accelerated regeneration of skeletal 
muscle (von Maltzahn  et al, in press). On the basis of increased levels of Cx43 expression 
in Cx39 deficient mice it has been hypothesized that Cx43 may compensate for the loss of 
Cx39 during regeneration. 
Taken together, these results show that, in regenerating skeletal muscle, at least four 
Cxs, out of five expressed in the regenerating muscle, can be differentially involved in 
communication of myogenic cells during the process of cell proliferation, aggregation, and 
fusion to form new myotubes or to repair damaged myofibers.  
 
 
Functional and morphological recovery of damaged skeletal muscle following 
low‐intensity endurance exercise 
 
Mdx mice 
The results of this study provide evidence for beneficial effects of low-intensity 
endurance exercise in muscle of mdx mice, leading to consistent recovery of damaged 
muscle and in less extent to muscle function improvement. In fact, despite the severe 
skeletal muscle degeneration occurring in sedentary mdx mice, in skeletal muscle of 
exercised mdx mice there was a marked reduction of dystrophic signs with strong reduction 
of necrotic foci and increase of regenerating and regenerated myofibres. On the other hand, 
the low-intensity endurance exercise did not show substantial muscle functional 
improvement, measured as fatigue resistance and forelimb strength, in exercised mdx mice 
as compared to sedentary mdx mice. This weak improvement in muscle function was in 
contrast to strong muscle morphological changes, with less necrotic fibers and greater 
increase of fully regenerated  muscle fibers. Hence, this study has provided further evidence 
that appropriate exercise parameters (frequency, intensity, duration, and mode) can indeed 
be critical for benefit on the recovery of  dystrophic muscle and therefore to decrease the 
progression of muscular dystrophy (Sveen et al. 2007; Grange and Call 2007; Dupont-
Versteegden et al. 1994; Wineinger et al. 1998). 
Concerning the mechanisms involved in this recovery of  dystrophic muscle, we may 
examine several possibility. Endurance training produces many physiological, metabolic and 
vascular adaptations in skeletal muscle (Febbraio and Pedersen 2005; Kaczor et al. 2007; 
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Faist et al. 2001; Vignos, Jr. and Watkins 1966; McCartney et al. 1988), but it is not clear 
how these changes may improve muscle pathology. Low intensity endurance exercise may 
have antinflammatory action (Zanchi et al. 2010; Nader and Lundberg 2009; Lira et al. 
2009). It has been proposed that an inappropriate or excessive inflammatory response can 
directly damage myofibers in mdx (Porter et al. 2002; Tidball 2005); whereas non steroidal 
anti-inflammatory or anti TNFα treatment prevents muscular dystrophy pathology, enhances 
regenerating ability of muscle and delay significantly and persistently the progression of 
muscular dystrophy (Brunelli et al. 2007; Grounds and Torrisi 2004). More likely, several 
factors released in response to endurance exercise may regulate muscle stem cells and 
therefore enhance the adaptive response of skeletal muscle (Hawke 2005; Charifi et al. 
2003). 
In our previous studies, in healthy runners was found an high numbers of circulating 
endothelial progenitors together with reduced hemopoietic progenitor counts, suggesting 
peripheral utilization of bone marrow-derived cells during endurance exercise (Bonsignore 
et al. 2010), and release of inflammatory and hematopoietically active growth factors  
(Bonsignore et al. 2002). These progenitors cells are tracked by growth factors released 
from muscle during injury or exercise and gradually change their phenotype becoming 
muscle stem cells. Further, it has been shown that a release of bone marrow-derived 
progenitors occurs after exercise and might be involved in repair processes at the level of 
skeletal muscle (Palermo et al. 2005; Labarge and Blau 2002). All together, although the 
mechanisms involved in the observed effect of regular and low-intensity exercise on skeletal 
muscle function in the dystrophic condition remains poorly understood (Sveen et al. 2007; 
Grange and Call 2007), it is however relevant that muscle lacking dystrophin can be 
recovered in response to specific endurance exercise.  
It is of interest that a controlled, relatively slow speed of running on a rotarod may 
induce beneficial adaptations to mdx muscles, which currently are susceptible to mechanical 
stresses that result in small disruptions of the muscle sarcolemma (Brussee et al. 1997; 
Lynch et al. 2000). In addition, the present findings showed that a well designed non 
voluntary endurance exercise may be not deleterious to dystrophic muscle, in agreement 
with previous data obtained by using similar exercise protocols, such as voluntary low-
resistance wheel running (Dupont-Versteegden et al. 1994; Hayes and Williams 1996; 
Radley et al. 2007), swimming exercise and low-intensity treadmill running (Hayes and 
Williams 1998). Because human dystrophic muscle shows several similarities to mdx 
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muscles, the present findings further support the usefulness of a low-intensity exercise as a 
potential therapeutic adjunct for human patients (Hayes and Williams 1998; Hayes et al. 
1993). 
To better evaluate the potential benefits of low-intensity endurance type of exercise on 
recovery of damaged dystrophic muscle, we measured also the expression of Cx39 gene that 
typically occur in response to regeneration process after muscle injury, leading to new 
myofibre formation (Trovato-Salinaro et al. 2009). This evaluation, not only testify for 
active regenerating process leading to new myofibres in sedentary mdx mice, but it also give 
to us the opportunity to use the Cx39 expression as marker to monitor the muscle 
regenerative process, and to know when a strong reduction of regenerating processes in 
muscle of exercised mdx mice take place, suggesting almost a full recovery of damaged 
muscle. Additionally, the disappearance of Cx39 expression in exercised mdx mice may also 
indicate that the designed endurance exercise did not induce damage of mdx mice myofibres, 
that notoriously are susceptible to mechanical stresses, resulting in small disruptions of the 
muscle sarcolemma and activation of regenerative processes.  
In conclusion, this study has shown that specific low intensity endurance exercise 
induces a strong beneficial effect on the regeneration of dystrophic muscle and may have 
therapeutic value at least to decrease progression of muscular dystrophy and in less extend 
for strengthening dystrophic muscle.  
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